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Decompression sickness (DCS) results from a sudden decrease in ambient pressure 
leading to super-saturation of tissues with inert gas and subsequent bubble formation 
within both tissues and blood. Perfluorocarbons (PFC) are able to dissolve vast amounts of 
non-polar gases. The administration of intravenous (I.V.) PFC emulsions reduce both 
 xv 
xvi 
morbidity and mortality of DCS, but the mechanism of this protective effect has not yet 
been demonstrated.  
Juvenile Dorper cross sheep between 16 and 24 kg (n=31) were anaesthetized and 
instrumented for physiological monitoring, the administration of I.V. fluids and sampling 
of arterial and mixed venous blood. Animals were placed in a hyperbaric chamber and 
compressed to 6.0 atmospheres absolute for 30 minutes, then rapidly decompressed. Upon 
chamber exit animals were randomly assigned to receive 6cc/kg of either PFC or saline 
control over 5 minutes beginning immediately after chamber exit. They were also 
randomized to receive one of 4 breathing gases post-chamber: 100% O2, 80/20 N2/O2, 
50/50 HeO2, or 80/20 HeO2. Blood samples were drawn at 5, 10, 15, 30, 60, and 90 
minutes to examine whole-body oxygenation. Respiratory gases were monitored and 
recorded in real-time using mass spectroscopy to examine nitrogen washout. 
PFC administration increased arterial oxygen content (16.30±0.27 vs. 14.75±0.25 
mL/dL, p<0.0001), oxygen delivery (14.83±0.28 vs. 13.44±0.25 mL/minute/kg, p=0.0004), 
and tissue oxygen consumption (3.37±0.14 vs. 2.76±0.13 mL/minute/kg, p=0.0018) over 
saline control, but did not increase mixed venous oxygen content (12.45±0.26 vs. 
11.74±0.24 mL/dL, p=0.0558) or extraction ratio (0.23±0.012 vs. 0.21±0.011, p=0.1869). 
PFC administration lowered the plateau of the curve, increasing the amount of 
nitrogen washout vs. saline control (22.22±1.566 vs. 15.98±1.380 mmHg, p= 0.0074). 
Breathing 80/20 HeO2 increased the decay constant of the curve, increasing the rate of 
washout vs. breathing 100% O2 (0.03176±0.001044 vs. 0.03096±0.0009402, p=0.5777). 
xvii 
PFC improves whole-body oxygenation after severe DCS and increases the amount 
of nitrogen washout. Although the effects of both PFC and 80/20 HeO2 breathing were 
statistically significant the magnitude of the nitrogen washout effect is quite small, and 
unlikely to be clinically significant. Thus it is likely that the improved oxygenation is 
responsible for the previously-observed therapeutic effects of PFC in treating DCS. 
 
 
CHAPTER 1 
 
GENERAL INTRODUCTION 
 
A Short History of Diving 
 Breath-Hold Diving 
The first human entry into the world beneath the sea was performed using breath-
hold diving. Exactly when and where this first took place has been lost to the ages, but 
there are archaeological claims that Neanderthals may have dived for food. We cannot be 
sure if they were diving, or rather were harvesting shellfish by wading at low tide(33, 125). 
We do know that by 4500 BC, diving had developed from limited and fear-filled 
excursions into a thriving industry that supplied the communities with shells, food, and 
pearls(33, 125). 
From those early times until now fishermen have used breath-hold diving to harvest 
products from the sea as diverse as fish, shellfish, pearls, shells, and sponges. Breath-hold 
diving was the only method available to access anything deeper than a few feet beneath the 
surface up until the nineteenth century when helmet diving equipment was developed(33, 
125). Breath-hold diving is still used today. Not only is it a recreational and competitive 
sport, but also used as a traditional fishing method by groups such as the Ama diving 
women of Japan and Korea, and pearl divers of the Tuamoto Archipelago(88, 125, 134). 
Originally the male divers were fishermen while the female divers collected shells and 
seaweeds that are important to Korean and Japanese cuisine. More recently diving duties 
have been restricted to the women while the men serve as tenders. This change has been 
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attributed by some to greater endurance of the women in cold water, while others pay 
homage to the traditional folklore that diving reduces the virility of males(134). 
Diving also has a long history of being used for strategic purposes. Divers are 
known to have been involved in military operations as far back as the Trojan Wars (1194-
1184 BC). Divers were used to sabotage enemy ships by boring holes in the hull below the 
waterline or cutting anchor ropes(33, 125). Divers were also used in the construction of 
underwater defenses to protect ports from attacking fleets(33, 125). Similarly, attackers 
would employ divers to remove obstructions. 
In North America in the sixteenth, seventeenth and eighteenth centuries, skilled 
native divers were able to descend to depths of 30 metres and remain submerged for up to 
15 minutes. The Spaniards exploited these native divers’ abilities to harvest pearls, salvage 
sunken ships, and even to smuggle goods past customs(33, 125). Demand for such divers 
was very high, indicated by their value on the slave market where prices of up to 150 gold 
pieces were paid(33, 125) 
Diving Equipment 
The earliest diving equipment to emerge was the snorkel. These simple breathing 
tubes made from reeds or bamboo were developed in many different parts of the world. 
This simple device allows a diver to breathe air from the surface with his or her head 
underwater. Writings from Aristotle imply that the Greeks used snorkels, though exactly 
what for is not clear(33, 106, 107, 125). Columbus also reported that the North American 
natives used snorkels for hunting waterfowl. They would submerge themselves and breathe 
through a reed while approaching birds floating on the water, and were then able to capture 
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the birds with nets, spears, and even with their bare hands(33, 106, 107, 125). Similar 
methods were also used by the Australian aborigine to hunt wild duck. Snorkels, however, 
do have serious limitations. Respiratory dead space increases with snorkel length. In 
addition, deeper dives place a greater load on the respiratory muscles.  Thus, snorkels are 
not useful deeper than 1-2 feet(33, 106, 107).  
Once these limitations were noted, the snorkel spawned the idea of a diver carrying 
a gas supply with them. An Assyrian drawing dated 900 BC is believed by some to picture 
an early diving set(33, 107, 125). The drawing depicts a man with a tube in his mouth and 
the tube connected to a bladder or bag. That such diving sets were not in use centuries later 
suggests that either this arrangement did not work well, or that the above interpretation 
could be incorrect, and that what is depicted is, in fact, something more akin to a float or 
life preserver(33, 107, 125). Leonardo da Vinci also developed ideas for diving sets. His 
sketches depict not only breathing equipment, but fins as well(33, 106, 107, 125). In one 
sketch he illustrates a long snorkel, which would not have worked well. In another idea he 
wrote of, and sketched ideas for providing a diver with a ‘wine skin to contain the breath’. 
This is most likely the first design of a self-contained breathing apparatus(33, 106, 107, 
125). These sketches by da Vinci appear tentative, so it is most likely safe to assume that 
there was no practical diving equipment being used in Europe in da Vinci’s time(33, 106, 
107, 125). 
Diving bells were the first successful method of allowing divers to remain at depths 
greater than could be reached with a snorkel and for durations longer than they could hold 
their breath. A diving bell consists of a chamber, weighted so it could sink and open at the 
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bottom, in which one or more people could be lowered under water. The early use of 
diving bells was limited to short durations in shallow water. The air contained within the 
bell would not support life for extended periods and its compression when submerged 
would limit the depth to which the bell could be lowered(33, 106, 107, 125). Use of this 
type of diving bell dates back to the mid-to-late 15th century(33, 106, 107, 125). A giant 
step forward was developed in 1691 by Sir Edmund Halley, after whom the comet is 
named, when he patented a diving bell which could be re-supplied with air in barrels(33, 
106, 107, 125). Weighted barrels of air were hauled from the surface and the air could be 
released into the bell. This development led to the more widespread use of diving bells for 
tasks such as salvage, treasure recovery, and construction. Dives to depths of 20 metres for 
durations as long as 90 minutes were recorded using this apparatus(33, 106, 107, 125). 
Similar diving bells, developed earlier and which probably served as the basis for Halley’s 
idea and patent, were used in Sweden for salvage. Between 1659 and 1665 divers were 
able to salvage 50 bronze canons weighing over 1000 kg each from the warship Vasa 
which sank in 30 metres of water in Stockholm harbour. The guns were recovered by 
divers in diving bells assisted by ropes from the surface(33, 106, 107, 125). That this was 
accomplished is truly amazing. It would be a difficult task now, even with the best of 
modern equipment.  
During the second half of the 18th century air pumps were developed that were both 
reliable and powerful enough to pump air against the pressures experienced by divers(33, 
106, 107, 125). These pumps led to the development of what are now called ‘open 
helmets’ for diving. In 1819 Augustus Siebe, a German coppersmith living in London, 
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developed a diving rig consisting of a copper helmet riveted to a leather jacket. Air would 
be pumped into the helmet, but there was no way to control the amount of air entering the 
suit. Excess air would simply bubble out of the jacket at the waist(33, 88, 107). Siebe’s 
original suit was quite successful, and was used in the salvage of the British warship 
H.M.S. Royal George(33, 88, 107). Its greatest shortcoming was that if the diver should 
fall, or if the pump or hose should leak it would quickly fill with water, be difficult to get 
out of, and the diver would most likely drown(33, 88, 107). Siebe continued his innovative 
design of diving apparati, and by 1837 he had developed a waterproof, full-body suit 
which could be bolted to a breastplate and helmet(33, 88, 125). With the emergence of this 
suit the diver could safely work in any position because the entire body was enveloped in 
the suit. With the suit now being a closed environment, inlet and exhaust valves were 
incorporated to allow the divers to regulate their buoyancy. This design was so successful 
that it remains essentially unchanged today. The United States Navy Mark V deep sea 
diving suit, which was in use up until 1986, is almost an exact copy of Siebe’s original 
diving suit, with some refinement in materials and improvement in the valves(88). 
Following the development of the diving suit it became possible for divers to dive 
to ever greater depths, and to remain at such depths for longer durations than had been 
possible with previous equipment. These deeper, longer dives were not accompanied by 
what we would think of today as appropriate decompression, and decompression sickness 
(DCS) was being noted in more and more divers(88, 125). 
 
 
6 
Decompression Sickness 
 The first recorded instance of what would now be referred to as DCS was recorded 
in 1670 by Sir Robert Boyle. In what is now thought of as a landmark experiment in 
alternobaric physiology, Boyle placed a viper in a vacuum chamber and was able to 
generate symptoms of DCS. In his journal he noted “I once observed a Viper furiously 
tortured in our Exhausted Receiver … that had manifested a conspicuous Bubble moving 
to and fro in the waterish humour of one of its eyes”(12, 88). In this experiment Boyle 
recorded that a rapid decrease in ambient pressure could result in the production of gas 
bubbles in body tissues.  
The earliest report of symptoms which are now believed to have been DCS in 
humans dates back to the 1840’s. The British warship H.M.S. Royal George sank at the 
Spithead anchorage near the Isle of Wight, and the wreck was a danger to navigation. 
Divers were employed to clear the wreck, and Colonel Pasley, the commander of the 
operation, noted symptoms of rheumatism and over-fatigue in many of his divers. These 
symptoms were attributed to dampness and cold, so divers were provided with fresh, dry 
undergarments. Other divers suffered paralysis which was attributed to zeal and over-
exertion(88, 125, 169). It is most likely that these men were suffering from DCS, 
especially given that their dives exceeded the now-accepted safe diving limits by a factor 
of 3(125, 169). 
The first records of DCS as such in humans come from a French mining engineer 
named Triger. Coal mines below the level of the water table were pressurized with air in 
order to keep the water out. In 1841 Triger noticed that some of the miners suffered cramps 
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and muscle pains after leaving the compressed air environment of the mine(125, 169). By 
1854 DCS was beginning to be understood. Pol and Watelle, two physicians in the employ 
of the Douchy Coal Company of Douchy, France began a systematic investigation of the 
symptoms experienced by caisson workers. They noticed that this disease was universally 
associated with leaving the compressed air environment, and noted that “one pays only on 
leaving”(88, 132). Pol and Watelle were also the first to notice that a return to the 
compressed air environment was effective in alleviating symptoms, and that younger men 
of 18 who had “not reached their greatest mature physical strength” suffered less from the 
symptoms of DCS than did men in their mid-30’s “who were in their prime”(88, 132).  
Over the next 30 years several small steps were made in the understanding of DCS. 
Boyle’s original experiments were repeated in 1857 by Hoppe-Seyler, at which time he 
described the obstruction of pulmonary blood vessels by bubbles, and noted that the heart 
was unable to adequately pump blood under these conditions(77, 169). He also suggested 
that the intravascular release of gas bubbles he had observed might be the mechanism 
underlying some of the cases of sudden death observed in caisson workers and divers. 
Hoppe-Seyler was also the first to suggest recompression as a therapy for DCS(77, 169). In 
1869, Le Roy de Mericourt, a French naval surgeon, reported on an occupational illness he 
observed amongst sponge divers in the Mediterranean which was attributed to the 
breathing of compressed air. He equated this with the illness observed in caisson workers 
and other divers(92, 125). The first review of compressed-air sickness research was 
conducted by Freidburg in 1872. He collected descriptions of symptoms of workers who 
received insufficient decompression after exposure to high pressure. He also compared the 
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clinical course of severe and fatal cases of DCS to that of the venous air emboli 
occasionally seen in obstetrics and surgery(125). He believed that rapid decompression 
resulted in the release of gas which had been taken up into tissue during the high-pressure 
exposure, and that the blood was filled with gas bubbles which interfered with circulation 
in the heart and lungs(125). Soon thereafter in 1873 Andrew Smith described what was 
becoming known as ‘caisson disease’ as a disease depending on increased atmospheric 
pressure, but always developing after reduction of the pressure(125, 144). This illness, he 
noted, was characterized by moderate-to-severe pain in one or more of the extremities and 
sometimes in the trunk. In some cases, there may be elements of paralysis which, when 
they appear, are most frequently confined to the lower extremities. Cerebral symptoms 
such as headache, vertigo, convulsions, and loss of consciousness may also be present(125, 
144).  
The first rigorous scientific study of DCS was carried out by the French 
physiologist Paul Bert and was reported in his seminal book of 1878 entitled La Pression 
Barometrique(7, 14, 88, 125). Bert was able to demonstrate that the symptoms of DCS 
were associated with bubbles in tissue, that these bubbles were formed during rapid 
decompression, and that these same bubbles consisted primarily of nitrogen(7, 88, 125). 
Bert also used various concentrations of oxygen to speed decompression, demonstrating 
the utility of oxygen breathing for the treatment of DCS, and was the first to propose the 
idea of oxygen recompression as a therapy for DCS(7, 125).  
The now common slang term ‘the bends’ evolved during the construction of the 
Brooklyn Bridge. This term was first noted by the above-mentioned Andrew Smith in 1894 
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while engaged as the medical advisor for the Brooklyn Bridge caisson work. The 
fashionable ladies of the period assumed a stooped posture while walking termed the 
‘Grecian bend’. When the workers emerged from the caissons afflicted by DCS, limping 
and hunched over from the pain in their legs, hips, and back, their colleagues would chide 
them for ‘doing the Grecian bend’(88, 125).  
The next major leap forward in the understanding and treatment of DCS came from 
an engineer rather than a physician or researcher. In 1889, efforts were underway to drive 
railway tunnels under the Hudson River. When the British engineer E. W. Moir took over 
as project superintendent the death rate among all workers from DCS was 25%. He erected 
a recompression chamber at the work site. Any worker showing signs of DCS was quickly 
recompressed and later decompressed at a slower rate. Up until this time, even though it 
was understood that recompression was able to alleviate the symptoms of DCS, since 
exposure to compressed air had caused the disease in the first place, physicians were loathe 
to recommend recompression as a cure(88, 125). Although he admitted in descriptions of 
his own work that he believed that his treatment was largely homeopathic, mortality from 
DCS amongst his workers decreased. By 1896 the recompression treatment Moir insisted 
on had reduced mortality to a mere 1.6% from 25% observed prior to his arrival(88, 111, 
169). 
By the dawn of the 20th century it was understood that DCS was a product of 
nitrogen gas bubbles evolving within the body as a result of decreasing pressure after 
exposure to a high-pressure environment.  It was also accepted that a return to increased 
pressure could relieve the symptoms, but there were no decompression schedules or 
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procedures that could be followed to reduce the risk of generating DCS in the first 
place(88).  
Decompression Planning 
Haldanian Theory 
In the early part of the 20th century there was a great deal of controversy regarding 
exactly how divers and caisson workers should be decompressed(165, 169). It was 
generally believed that the best way to avoid DCS was to ascend to the surface at a slow, 
uniform rate. There was no consensus regarding what constituted an appropriately slow 
rate(1, 165). The Royal Navy Diving Manual specified an ascent rate of 5 feet/minute, 
while the French physiologist Paul Bert was advocating for an ascent rate of 3 feet/minute. 
The German physiologists Heller, Mager and von Schrotter recommended an ascent rate of 
1.5 feet/minute(165). In spite of all these recommendations, DCS was still alarmingly 
common amongst divers and caisson workers(165).  
The first step towards safe diving was a product of the work of the Scottish 
physiologist John Scott Haldane. His critical supersaturation ratio hypothesis formed the 
basis of the first decompression tables. Exactly how Haldane persuaded the Royal Navy to 
investigate his hypothesis is not known. Navy submarines were sinking, the divers 
salvaging them were at risk, and the little-known fact that his older brother was the 
Minister of War may have influenced the decision(4, 165).  
By Haldane’s time Bert had established that the signs and symptoms of DCS were 
often associated with nitrogen bubbles in blood and tissue(7, 165). He was also struck by 
the powerful impact that long exposures at depth had on the appearance of DCS. For 
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example a salvage diver working for the Siebbe-Gorman company salvaged £70,000 in 
gold bullion from a wreck sitting in 162 feet of seawater (fsw) over the course of 33 safe 
dives with 25-minute bottom times. For a single dive he extended his bottom time to 45 
minutes. After this dive he developed paralysis from which he never fully recovered(165). 
Likewise another diver working for Siebbe-Gorman salvaged silver from several wrecks at 
depths ranging from 174 to 180 fsw with bottom times ranging from 8 to 13 minutes. After 
approximately 70 safe dives using this profile he extended his bottom time to 40 minutes. 
Upon surfacing he experienced great pain and ruptured blood vessels with blood 
accumulating under the skin. His condition was so serious that a priest was called and 
administered last rites, but he survived and was back working a week later(165). 
These cases, and others like them, suggested to Haldane that a diver’s tissues 
absorbed nitrogen in a time-dependent manner while under pressure as arterial blood 
carried dissolved nitrogen from the lungs to other body tissues. When the diver ascended 
and the pressure decreased some excess nitrogen in tissue could be safely tolerated, but too 
much would cause bubbles to form and result in DCS(165). 
To examine what sort of time-depth combinations could be tolerated Haldane 
performed a series of experiments in goats. He exposed them to 2.36 atmospheres absolute 
(ATA) for 2 hours and then rapidly decompressed them to surface pressure (1 ATA). This 
pressure drop of 1.36 ATA produced DCS in some animals(55, 169). He also found that 
the same absolute decrease in pressure of 1.36 ATA from 6 ATA did not produce DCS, but 
rather a decrease of 3 ATA was required to cause DCS(55, 169). From this he deduced that 
DCS was not a product of an absolute decrease in pressure. Instead, he theorized, DCS was 
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caused by a relative decrease in pressure. More specifically he hypothesized that pressure 
could be decreased in a 2:1 ratio without causing DCS.  Thus, if a dive was conducted to 6 
ATA, the diver could safely ascend to 3 ATA where a stop needed to be made or if a dive 
were conducted to 4 ATA, the diver could safely ascend to 2 ATA where a stop needed to 
be made(55, 169). This is known as the ‘critical ratio’ supersaturation hypothesis and led 
to the idea of ‘stage decompression’. From here, Haldane made some assumptions: First, 
that the uptake and elimination of nitrogen followed an exponential pattern. Second, that 
the body could be represented mathematically using 5 different ‘tissue compartments’ with 
nitrogen loading and unloading half-times of 5, 10, 20, 40 and 75 minutes. These ‘tisue 
compartments’ are purely mathematical constructs. They do not directly equate to any 
tissue in the body. From these data and assumptions Haldane devised the first dive tables.  
Haldane’s ‘Table I’ was used for dives to depths of up to 204 fsw with decompression 
times up to 30 minutes – see Table 1. This table proved to be very successful and virtually 
eliminated DCS, but over time was found to call for decompression stops that were both 
deeper and longer than were necessary in practice(165, 169). Haldane’s ‘Table II’ was 
used for dives with bottom times exceeding 1 hour requiring over 30 minutes of 
decompression. It was found to generate decompression schedules that were insufficient to 
prevent DCS(165, 169) – see Table 2.  
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Table 1: Table I of appendix IV from J. S. Haldane’s ‘The prevention of 
compressed air illness’(55) 
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Table 2: Table II of appendix IV from J. S. Haldane’s ‘The prevention of 
compressed air illness’(55) 
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Neo-Haldanian Developments 
As Haldene’s ideas and findings were carried to other countries, including France, 
Russia, and the United States, Haldane’s original tables were modified in search of safe 
and efficient decompression schedules. The United States Navy found that Haldane’s 
original 2:1 supersaturation ratio was too conservative for short dives, limited by nitrogen 
accumulation in tissues with short nitrogen loading half-times, producing decompression 
schedules that were longer than necessary. At the same time this 2:1 ratio was found not to 
be conservative enough for long duration dives where decompression is limited by tissues 
with long nitrogen loading half-times, resulting in an unacceptably high number of cases of 
DCS(169). These experiences indicated that Haldane’s critical supersaturation ratio was 
not fixed at 2:1 under all conditions. Work for the United States Navy by Yarbrough in the 
1930’s found that the critical supersaturation ratio was different for each of the 
hypothetical tissue compartments in the mathematical model, but also varied with the 
duration of exposure, or dive time(169, 187). Subsequent work by Des Granges, Dwyer, 
and Workman showed that the critical supersaturation ratio also varied with depth(27, 36, 
169, 185). This ultimately led to the replacement of the critical supersaturation ratio with a 
series of tables of ‘M values’ by Workman. (169, 185) – see Table 3. These showed the 
maximum allowable supersaturation for each of the hypothetical tissue compartments in 
the model at each depth. This work represented an enormous leap forward in the 
understanding of the physiology of DCS and, with the addition of a 120-minute nitrogen 
loading half-time tissue compartment to the model, formed the basis of the 1956 United 
States Navy dive tables, which, with a few minor modifications, are still in use today(165, 
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169). In fact, the vast majority of dive tables, or decompression tables in use today are 
direct outgrowths of Haldanian and neo-Haldanian approaches and understanding.  
 
Table 3: Workman M-values(185). The maximum allowed (absolute) partial 
pressure of nitrogen M in a hypothetical tissue compartment characterized by the half-time 
τ is defined as follows: 
 
 M = M0 + ΔMD 
 
Where M = partial pressure limit for each tissue compartment (τ) in metres of 
seawater (msw) 
 M0 = partial pressure limit at sea-level (zero depth) (msw) 
 ΔM = increase of M per metre of depth (msw/m) 
 D = depth (m) 
 
τ (minutes) M0 (msw) ΔM 
5 31.7 1.80 
10 26.8 1.60 
20 21.9 1.50 
40 17.0 1.40 
80 16.4 1.30 
120 15.8 1.20 
160 15.5 1.15 
200 15.5 1.10 
240 15.2 1.10 
 
In more recent years as divers have been venturing ever deeper for longer durations 
even these neo-Haldanian tables proved to be inadequate. More and more tissue 
compartments were needed in the model to produce decompression schedules with 
adequate safety. These models grew from the original 5 compartments in Haldane’s model 
to as many as 20 with nitrogen loading half-times as long as 1000 minutes for extreme 
exposures(169).  
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Other Hypotheses 
As often happens in any area of research, shortly after Haldane’s pioneering work 
dissenting opinions began to appear. In 1912, Sir Leonard Hill produced both experimental 
and theoretical evidence questioning the value of stage decompression over continuous, 
uniform decompression(67). Hill believed that Haldane’s stage decompression allowed gas 
bubbles to form in tissue and then attempted to limit their growth by applying 
decompression stops whereas using a slow, linear decompression could prevent bubble 
formation altogether. Although Hill’s techniques are now used extensively in 
decompression from long duration saturation exposures such as are used in very deep 
water by the oil and gas industry, his inability to explain why Haldane’s technique was 
able to avoid DCS, combined with the practical value of the ease-of-use of Haldane’s 
tables meant that Haldane won out with the British Royal Navy in the early 1900’s(67, 
169).  
Decades later, in the early 1960’s, Brian Hills & Hugh Le Messurier observed that 
Okinawan pearl divers using air as a breathing gas were able to dive to depths of 90 metres 
for durations of up to one hour, twice a day, six days per week. These people, as a group, 
had accumulated enormous experience. They were working without any preconceived 
scientific framework and were eventually able to produce safe decompression procedures. 
These procedures were arrived at through trial and error and were very expensive in terms 
of lives lost during development. Their procedures required approximately 33% less 
decompression time than the United States Navy tables(93). Hills therefore suggested that 
DCS develops in the early stages of ascent. He believed that adding deeper decompression 
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stops rather than extended shallow stops would decrease the incidence of DCS. A study he 
conducted in the United Kingdom demonstrated that this theory was correct. By moving 
the conventional 3 metre (m) decompression stop to 6 m, the incidence of decompression 
sickness was decreased by 40%(70, 169).  
Observations such as these led to Hills postulating a ‘thermodynamic’ model of 
DCS and introduced the concept of ‘unsaturation’ to the understanding of bubble 
prevention and resolution(69, 71, 72, 75). The concept of unsaturation is best illustrated by 
examining representative values for the partial pressures of respiratory gases for a person 
under normal atmospheric pressure - see Table 4. 
 
Table 4: Partial pressures of respiratory gases at 1 ATA(174) 
Gas Partial Pressure 
O2 CO2 N2 H2O Total Sample 
(mmHg) (mmHg) (mmHg) (mmHg) (mmHg) 
Inspired Air 158 0.3 596 5.7 760 
Expired Air 116 32 565 47 760 
Alveolar Air 100 40 573 47 760 
Arterial Blood 100 40 573 47 760 
Venous Blood 40 46 573 47 706 
Tissues ≤30 ≥50 573 47 700 
 
It is clear from Table 4 that the total gas tension in tissues is less than the ambient 
barometric pressure, thus the tissue is ordinarily unsaturated, and others have suggested 
that the degree of unsaturation may be higher than the 60 mmHg indicated in Table 4 
above(75, 169). The importance of this tissue unsaturation in diving is that an 
instantaneous reduction in pressure equal to at least 60 mmHg (an ascent of 2.6 fsw) is 
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required before tissues become saturated with gas(70, 75, 169). After this ascent the 
alveolar partial pressure of nitrogen is less than the tissue partial pressure of nitrogen so a 
pressure gradient is established, and to balance this gradient nitrogen is eliminated from 
tissue, re-establishing tissue unsaturation(70, 75, 169). This suggests that the speed at 
which gas is taken into tissue or eliminated from tissue is critically important to the 
development of DCS. For example, when astronauts are operating outside the space 
vehicle in space suits, the suit is pressurized to 0.2-0.3 ATA. In order for astronauts to 
operate in this low-pressure environment they must first pre-breathe 100% oxygen for 3 
hours to remove nitrogen from their bodies. If the astronaut breathes room air for as little 
as 5 minutes after this denitrogenation they will develop DCS at suit pressure(169). Only 
the ‘fast’ tissues, those with very short nitrogen loading half-times could be involved in 
this sequence. This is likely a result of the fact that several nitrogen gradients are 
developed at the same time by the depressurization. Not only is there a gradient from these 
‘fast’ tissues to alveolar gas, but there is also a gradient from these ‘fast’ tissues to ‘slower’ 
tissues, and they will continue to absorb gas from the faster tissues, even after the pressure 
has stabilized, until the whole system reaches equilibrium. In this way the ‘fast’ tissues 
serve not only as the depot to which nitrogen is added to and removed from the body, but 
also as a source of nitrogen to slower tissue compartments, as illustrated in Figure 1. 
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Figure 1: Graphical representation of tissue on- and off-gassing. 
 
Nitrogen is loaded into tissues based on the partial pressure to which it is exposed. 
This figure represents how N2 would move into and out of theoretical tissue compartments 
with half-times ranging from 5 to 520 minutes during and after a dive to 6.0 ATA (165 
fsw) for 30 minutes. Notice that gas continues to load into compartments with slower half-
times even after the dive is over. This is because the nitrogen in the faster half-time 
compartments moves not only out of the body via the lungs, but into slower half-time 
compartments which are less filled. 
 
The next leap in understanding DCS began in 1951 when Harvey postulated the 
importance of bubble nuclei in the formation of bubbles in DCS(63). This went largely 
unnoticed until 1977 when Yount et al. integrated Harvey’s ideas about bubble nuclei with 
the concept of unsaturation(194). This led to new theories about bubble formation and 
growth and began a revolution in thinking about decompression planning. Up until this 
time all dive tables were based to some degree on the work of Haldane. The one critical 
failing of Haldanian and neo-Haldanian approaches is the fact that there is the inherent 
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assumption that all gases remain dissolved. If gas should come out of solution and form 
bubbles, it is effectively lost to the calculations, despite the fact that it was well-understood 
that bubbles were the root of DCS.  
Yount proposed that there are stable gas micronuclei that can act as seeds for 
bubble growth(194). Greatly simplified, bubble growth is a function of internal pressure 
vs. external pressures acting on the bubble. The internal pressure (Pb) is due to the gas 
molecules contained in the bubble, and is a product of the combined partial pressures of all 
dissolved gases in the immediate environment of the bubble. The external pressures 
include the ambient pressure (Pa), tension due to tissue displacement (Pt), and the surface 
tension of the bubble (Py). If  then the bubble will grow, if 
then the bubble will shrink(169, 194). Bubble growth can follow 
decompression when P
b a tP P P P> + + y
yb a tP P P P< + +
b reflects the pressure of gases (especially nitrogen) at a greater 
depth and Pa is decreasing. Similarly, bubbles can grow in areas of turbulent blood flow 
where Pt is reduced. The effect of Py will vary with the size of the bubble according to the 
Law of LaPlace: 2y
yP r=  where Py = pressure due to surface tension, y = surface tension 
and r = radius of the bubble. For large bubbles Py is reduced, and may become negligible. 
For very small bubbles Py may become so great as to force the bubble back into 
solution(169, 194). Given the above, it is difficult to understand how extremely small 
bubbles are able to persist except in protected environments. Further work by Yount 
demonstrated that even though bubbles of diameters greater than 1 μm should float to the 
surface of standing liquids or gels and bubbles smaller than this should dissolve within a 
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few seconds, that there are stable microbubbles present in most liquids and gels which can 
act as seeds for the development of DCS(190, 191, 194, 195).  
These findings gave birth to a new way of thinking about DCS. Ultimately they 
resulted in a radical change in decompression planning – what are now called dual phase 
models. These models account for dissolved gas much like neo-Haldanian models do, but 
also track free gas in the form of bubbles. They seek to shape a decompression profile in 
order to minimize the number of bubbles formed, as well as their total volume(178-181, 
188, 191-193). The two best developed models of this type are the Varying Permeability 
Model (VMP) and the Reduced Gradient Bubble Model (RGBM)(176-179, 181, 188, 190, 
191, 193). These represent the most advanced decompression models currently in use. 
These dual-phase models operate fundamentally differently than the dissolved-
phase (Haldanian and neo-Haldanian) models. Dissolved-phase models seek to prevent 
DCS by removing excess nitrogen as quickly as possible. This is done by ascending to 
depths as shallow as is safe, followed by long, shallow decompression stops. Dual-phase 
models, on the other hand, seek to minimize the number and, more importantly, the total 
volume of bubbles free in circulation. This is achieved by requiring short decompression 
stops beginning at depths much greater than dissolved-phase models would recommend. 
This keeps the ambient pressure relatively high, promoting gas dissolution out of the 
bubbles and elimination via the lungs, resulting in bubble shrinkage. These dual phase 
models result in decompression schedules which are both shorter and statistically  produce 
fewer incidents of DCS(176-179, 181, 188, 190, 191, 193). 
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RGBM in particular has been used to plan and execute extraordinary dives which 
would not have been possible using dissolved-phase models. For example, on 17 
December, 2007 two divers from the Woodville Karst Plains Project, Jarrod Jablonski and 
Casey MacKinlay, entered the Turner Kink near Tallahassee, FL. They descended to a 
depth of 300 fsw where they entered an underwater cave system. They penetrated an 
amazing 11.25 km into the cave system before turning around and exiting the way they 
came in. The cave penetration itself required 6 hours, and an additional 14 hours of 
decompression time was required before the two divers could exit the water. Neither of 
these divers developed any signs or symptoms of DCS(61, 182). This dive would not have 
been possible prior to the advent of dual-phase models for decompression planning. 
Physiology and Pathophysiology of Decompression Sickness 
 What is Decompression Sickness? 
DCS is a much less well understood phenomenon than researchers in the field 
would like people generally to believe. Understanding the physiology and pathophysiology 
of DCS is complicated by several factors. Chief among them is the simple fact that a 
diagnosis of DCS is entirely based on history and symptoms. There exist no medical tests 
to either rule in or to rule out DCS. Furthermore, DCS is a stochastic phenomenon. If ten 
people were all subjected to the same dive profile designed to produce some symptoms of 
DCS, some would suffer from DCS symptoms while others would not. Among those that 
developed symptoms, there would be a wide range of presentations from mild joint pain to 
serious neurological symptoms such as parasthesia and paralysis - see Table 5. Similarly, if 
one person were subjected to the same dive profile in the example above on ten different 
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occasions, they would most likely develop symptoms of DCS on some occasions, and not 
on others, and just as above, the symptoms they develop are likely to vary from one 
exposure to the next. At this time there doesn’t exist a clear understanding of all the factors 
that contribute to DCS, let alone how they affect the onset and development of DCS. For 
these reasons DCS remains very difficult to predict in any terms other than statistical 
probabilities.  
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Table 5: Frequency of signs and symptoms in 935 cases of decompression 
sickness(138) 
 
Sign or Symptom Number of 
Instances 
Within 935 
Cases 
Percentage of 
Instances Within 
935 Cases 
Number of 
Instances 
Manifested 
Initially 
Percentage of 
Initial 
Manifestations 
Localized pain 858 91.8 744 76.6 
Numbness or paresthesia 199 21.2 41 4.3 
Muscular weakness 193 20.6 8 0.8 
Skin rash 140 14.9 42 4.4 
Dizziness or vertigo 80 8.5 24 2.5 
Nausea or vomiting 74 7.9 8 0.8 
Visual disturbances 64 6.8 14 1.4 
Paralysis 57 6.1 2 0.2 
Headache 37 3.9 5 0.5 
Unconsciousness 26 2.7 6 0.6 
Urinary disturbances 24 2.5 0 - 
Dyspnea (“chokes”) 19 2.0 4 0.4 
Personality change 15 1.6 0 - 
Agitation or Restlessness 13 1.3 0 - 
Fatigue 12 1.2 2 0.2 
Muscular twitching 12 1.2 0 - 
Convulsions 11 1.1 0 - 
Incoordination 9 0.9 0 - 
Equilibrium disturbances 7 0.7 0 - 
Localized edema 5 0.5 0 - 
Intestinal disturbance 4 0.4 0 - 
Auditory disturbance 3 0.3 0 - 
Cranial nerve involvement 2 0.2 0 - 
Aphasia 2 0.2 0 - 
Hemoptysis 2 0.2 0 - 
Subcutaneous emphysema 1 0.1 0 - 
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The study of the physiology and pathophysiology of DCS is also complicated by 
the fact that DCS is a symptomatic diagnosis. Firstly, it is unethical to conduct randomized 
trials in people, deliberately subjecting them to a condition which could cause permanent 
injury or death. Likewise the invasive measurements needed to best understand what is 
happening in the midst of DCS are also not ethical for human use. Secondly, studies in 
animals are complicated by the simple fact that animals are not able to report on their 
symptoms. This makes it very difficult to ascertain to what degree the symptoms generated 
in animal experiments mimic what is observed in humans. None the less, great strides have 
been made in understanding the physiology and pathophysiology of DCS over the last 340 
years, as was touched upon above. These advances will now be elaborated upon and 
examined from the perspective of physiology, rather than that of history. 
 The consensus in the hyperbaric community is that DCS is the result of the 
formation of gas bubbles in tissue and anatomic spaces unsuited to the presence of gas 
upon decompression, however, the presence of such gas bubbles does not inevitably lead to 
DCS(34, 45, 170). Gas bubbles in tissue may produce no symptoms at all or may produce 
symptoms ranging from pruritis, fatigue, or joint and muscle soreness to permanent 
paralysis, convulsions, and death(34). The term ‘decompression sickness’ is generally used 
to refer to the pathologic response to the development of bubbles in tissue and blood, while 
the term ‘decompression illness’ is used as a general term to denote any injury or illness 
which is a consequence of a reduction in ambient pressure, including, but not limited to 
DCS, barotraumas, as well as both arterial and venous gas emboli. 
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DCS, as defined above, is a product of a rapid decrease in ambient pressure(34). At 
equilibrium the amount of gas dissolved in any given tissue is proportional to the partial 
pressure of that gas to which the tissue is exposed according to the physical principal 
known as Henry’s law. The gas partial pressure to which tissues are exposed is primarily a 
product of ambient pressure and the gas mix being breathed. When ambient pressure 
decreases, bubbles will form in the tissue unless the gas can either be taken up by tissue, as 
would be the case with O2 or CO2, or carried down a concentration gradient and ultimately 
equilibrate with the gas partial pressures in the alveoli, from which they can be exhaled 
through the lungs, as would be the case for inert gases(34). When this reduction of ambient 
pressure is sufficiently gradual, the removal of excess gas proceeds safely(34, 55, 67). 
When ambient pressure is decreased both too much and too rapidly it is believed that gas 
bubbles form and result in the symptoms of DCS, but exactly how and where in the body 
these bubbles form remains poorly understood(32, 170). What is understood is that part of 
the mechanism of injury in DCS is the mechanical effects of these bubbles, be that the 
compression and distortion of tissue surrounding the growing bubble, or obstruction of 
blood flow by bubbles lodged in arterioles, capillaries or venules(34, 169, 170). 
How and Why Bubbles Form 
Water, and thus water-based fluids, can tolerate very high levels of supersaturation 
before bubbles begin to form de novo within the water itself. In fact, in pure water, 
supersaturation itself will not produce bubbles until this supersaturation is approximately 
1000 ATA. That is to say, if water exposed to room air is normally saturated with 0.79 
ATA of nitrogen, then the nitrogen partial pressure would need to exceed 790 ATA in 
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order to generate de novo bubble formation as a result of supersaturation alone(66, 169). 
Since DCS can develop with supersaturations considerably less than this, there must be 
other mechanisms involved in addition to supersaturation by itself. There are two 
mechanisms for the formation of bubbles, with much lower degrees of supersaturation 
necessary, which are believed to be at play in the body. The first of these is the process by 
which bubbles can grow from pre-existing, stable micronuclei already present in 
tissue(115, 169, 189). With any sort of imperfection in a surface, very small pockets of gas 
can develop and remain stable in environments which, without the stabilizing effects of the 
crevice in which they reside, would collapse and dissolve. The presence of such stable 
‘micronuclei’ has been previously demonstrated by Yount et al(190, 191, 194, 195). When 
supersaturation of the liquid develops, gas molecules can diffuse into these micronuclei 
and they will expand, bulging out of the crevice into the surrounding liquid. Surface 
tension at the gas-liquid interface tends to oppose this growth, but it will continue as long 
as the liquid is sufficiently supersaturated for gas to diffuse into the forming bubble. When 
the forming bubble reaches a critical size, surface tensions will pinch off the budding 
bubble and release it into the liquid leaving the micronucleus behind to repeat the process 
so long as the state of supersaturation persists(115, 169, 189). This is the process by which 
bubbles are released from carbonated beverages and why the bubbles appear to stream 
from certain points on the wall of the glass. This is illustrated in figure 2 below. 
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Figure 2: Nucleation of bubbles from pre-existing micronuclei with 
decompression. 
 
Stable gas micronuclei exist within microscopic imperfections in surfaces. When 
the surrounding liquids are supersaturated with gas, gas will dissolve into the micronucleus 
causing it to grow and bud out into the liquid. Once the bubble reaches a critical size 
surface tension effects will cause the bubble to be pinched off and released into the liquid 
leaving the micronucleus behind to repeat the process.  
 
The second mechanism likely at play is called tribonucleation, or cavitation 
nucleation. Local areas of very low pressure are created within the body by several factors 
including vertical motion in areas of turbulent blood circulation, and the shearing forces 
created within joints as solid structures move away from each other. The extremely low 
pressures generated in these environments can exceed 1000 ATA below ambient pressure, 
and is sufficient to allow for the spontaneous formation of bubble nuclei, which can then 
grow as gas from the supersaturated blood and tissue diffuses into the bubble(109, 166, 
169). This same process can take place even when tissue is not supersaturated with gas. 
The formation and collapse of bubbles formed by tribonucleation is responsible for the 
sound of knuckles cracking(34, 165, 169).  
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Where Bubbles Form and Where They Are Found 
Where such bubbles form is even less well understood than how they form. In 
theory, bubbles can form in any liquid environment, including within cells, in extracellular 
fluid spaces, and within the blood and lymphatic circulations, as well as in cerebrospinal 
fluid (CSF). The intracellular formation and growth of bubbles would result in membrane 
rupture and functional loss similar to what is observed with the formation of intracellular 
ice crystals in frostbite. Bubbles have been observed to form and grow in decompressed 
hen’s eggs, but unicellular organisms and erythrocytes in suspension have proven to be 
very resistant to intracellular bubble nucleation(62, 65, 121). None the less, it has been 
inferred that intracellular gas bubbles do form in mammals from observed mitochondrial 
membrane abnormalities and intracellular bubbles have been observed in some adipocytes 
of rapidly decompressed rodents(6, 46). Some of the space-occupying lesions observed in 
myelin sheaths may have begun as intracellular bubbles(6, 40, 46, 158). Although 
intracellular bubbles probably do form, their clinical importance is likely overshadowed by 
other events(34). 
Bubbles may also form in the extracellular, extravascular space. In fact, the earliest 
report of DCS commented on the presence of a bubble in the aqueous humour of a viper’s 
eye(12). Similar observations have also been recorded in dogs(22). Likewise, bubbles have 
been reported to be present in the urine, CSF, and tear film of acutely decompressed 
animals(55, 156). It is unlikely that bubbles formed in these extracellular fluids produce 
any clinical symptoms(34). During the development of the first deep water diving tables, 
numerous holes were found to be present in fixed tissue of the spinal cords of goats that 
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had developed DCS(55, 60). Since that time many other investigators have reported the 
presence of empty spaces in the white matter of fixed spinal cords that compress and 
distort surrounding structures after decompression(40, 108, 122, 158). These spaces were 
found to be more common in decompressed animals than in control animals, thus it is 
unlikely that they were purely fixation artifacts(40, 108). They appeared to compress 
surrounding structures suggesting that the empty spaces were growing bubbles(40, 108). It 
is difficult to determine if the origin of these bubbles was intracellular, extracellular, or 
intravascular due to the distortion of surrounding tissues. Gas bubbles that appear to be 
extracellular have been observed in the peripheral nerve myelin of decompressed guinea 
pigs, suggesting that the spinal cord lesions may, indeed, have been extracellular in 
origin(34, 47). 
The most common location where gas bubbles either form, or end up is in the 
intravascular space. Intravascular bubbles produce symptoms by interfering with blood 
circulation. Arterial gas bubbles are more likely to result in serious pathologic 
consequences than are venous bubbles(34, 170). Intravascular gas bubbles have been 
directly observed in vivo after decompression in the arteries and veins of the hamster cheek 
pouch, in the spinal epidural veins, posterior spinal arteries, and cranial arteries and veins 
of dogs(13, 15, 47, 56, 101). There have also been numerous reports of intravascular gas 
bubbles in humans after fatal DCS(24, 64, 123). The in vivo occurrence of intravascular 
bubbles in humans is inferred from the observation of abnormal ultrasound signals using 
Doppler flow meters and ultrasound scans(5, 38, 82). These techniques are only able to 
detect moving bubbles and small bubbles are difficult to distinguish from solid 
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emboli(105). The Doppler signal is auditory and is usually recorded and later graded by 
experienced observers. This type of analysis lends itself to bias if the observers are aware 
of the experimental conditions. Any movement of the transducer is also very likely to 
generate signal artifacts. Despite these limitations, Doppler ultrasound is an accepted tool 
in DCS research(34).  
Intravascular bubbles associated with DCS are most often confined to the venous 
side of the circulation. Arterial bubbles are rarely observed, but when present they usually 
accompany serious symptoms of DCS(34). It is unlikely that bubbles form directly in the 
arteries since the relatively high arterial blood pressure opposes their formation and the 
arterial blood, having just passed through the lungs, has inert gas tensions close to ambient 
pressure(34). Arterial bubbles are usually a result of one of two causes: pulmonary 
barotrauma or right-to-left shunts, either in the heart or in the lungs. Pulmonary barotrauma 
is most often a product of air trapped within the broncho-alveolar tree expanding on 
decompression. This results in tearing of the lung parenchyma and vasculature and air 
being forced into the pulmonary veins with overpressurizations as small as 29.5 kPa or 4.2 
psi(136, 186). Right-to-left shunts in the heart usually take the form of atrial septal defects, 
such as a patent foramen ovale. Approximately 20-30% of the human population have 
defects such as this(157). Several studies have indicated that patent foramen ovale is much 
more common among divers that develop severe DCS than in the general population(113, 
183). This suggests that atrial septal defects are commonly associated with severe DCS, 
but whether or not they increase the risk of developing DCS, and to what degree, is 
unknown(34). The lungs are ordinarily a very efficient filter of the bubbles present in the 
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venous circulation after decompression(16, 73). However massive numbers of bubbles in 
the venous circulation can overwhelm the ability of pulmonary capillaries to filter out such 
microemboli(16, 73). Large numbers of bubbles also lead to the opening of pulmonary 
arteriovenous shunts, as well as increased pulmonary arterial pressure, both of which 
contribute to passage of bubbles through the lungs into the arterial circulation(18, 114). 
These mechanisms are likely involved in cerebral DCS as it has been observed that after 
severe DCS in dogs known to be without atrial septal defects, the first bubbles to appear in 
the cerebral circulation appear in the arteries(34) 
Non-Mechanical Effects of Bubbles 
Bubbles causing distortion of tissues and obstructing blood flow would be injurious 
in and of itself, even if the body did not react in any way to the presence of the bubbles. 
However, blood is a highly reactive, living tissue which is primed to respond to any 
deviation from its normal environment(34). The presence of bubbles in circulation is 
sufficient to trigger many of these responses(34). Endothelial cells are key players in the 
regulation of blood coagulation and the regulation of microcirculatory blood flow. 
Endothelial cells are often damaged by the passage of bubbles, even bubbles small enough 
to pass through the vessel without lodging and obstructing blood flow(74, 164). The blood 
gas interface is capable of denaturing proteins because the hydrophobic portions of the 
proteins will have a lower free energy when surrounded by air than by blood plasma(95). 
This protein denaturation can lead to the accumulation of free fat globules and bubble 
formation can provoke the release of free fatty acids from cell membranes(34, 64, 96). The 
accumulation of such products can result in the formation of fat emboli, which have been 
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observed in several pathologic studies of DCS, and may contribute to the central nervous 
system damage associated with DCS(34, 64, 96). 
The presence of bubbles is also able to activate coagulation and complement 
systems. Bubbling of air through cell-free blood plasma has been shown to decrease 
clotting time, presumably through the activation of the contact system activator known as 
Hageman factor(57, 58). Hageman factor activates the intrinsic pathway for thrombin 
formation and activates the system for kinin formation(41, 119). This results in pain, 
vasodilation, edema formation, leukocyte chemotaxis, and activation of the plasma 
fibrinolysis system(41, 119). The net effect of the activation of these systems is 
progressive clotting and subsequent ischemia at and around the site of the bubble(41, 119). 
These activated factors are also distributed systemically and likely contribute to leukocyte 
trapping in the lungs and systemic reactions to decompression such as fatigue(34). 
Complement activation by bubbles has been noted in rabbit serum and rabbits depleted of 
complement have been found to be resistant to DCS(20, 171, 173). While complement 
activation is certainly seen with DCS, exactly how it contributes to the pathology of DCS 
is poorly understood due to conflicting reports in the literature regarding the correlation of 
activated complement with severity of signs and symptoms of DCS(76, 153, 172).  
Human studies have shown increased packed cell volume and decreased platelet 
counts after decompression(127). These findings are consistent with the development of 
edema and activation of thrombin, which would further impair blood flow in the 
microcirculation by increasing blood viscosity(34). Electron microscopy studies have 
shown that leukocytes and platelets adhere to both circulating bubbles and damaged 
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endothelium(128). These cells have also been shown to accumulate in areas of low blood 
flow after arterial air embolism in the brain(35, 59, 118). Leukocyte depletion has been 
shown to reduce the severity of neurophysiologic damage induced by cerebral air 
embolism(35, 59, 118).  
Bubbles, it would appear, are the root cause of the signs and symptoms of DCS. 
The injury induced by the presence of bubbles is not limited to direct mechanical 
interaction of bubbles with tissue. The presence of bubbles, particularly in the blood, will 
also activate multiple biochemical pathways that ultimately lead to thrombosis and edema, 
as discussed above. This can have detrimental effects which outlast the presence of the 
bubbles that triggered the activation in the first place. 
Perfluorocarbons 
Perfluorocarbons and Oxygen 
The emergence of perfluorocarbon (PFC) emulsions as medical therapeutics is 
largely a product of the dangers of viral transmission associated with blood transfusion in 
the early-to-mid 1980’s(147). With the advent and refinement of viral marker testing in the 
1990’s, the risk of viral transmission decreased dramatically, but there remain risks 
associated with blood transfusion that can never be eliminated such as ABO and Rh 
incompatability, graft-vs.-host disease, volume overload, and immunosuppression(147). In 
part as an effort to deal with these risks, the development of safe and efficacious 
intravenous (I.V.) oxygen therapeutics, or ‘blood substitutes’, continues to be investigated. 
Perfluorocarbon emulsions are one of the lines of products currently being investigated. 
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Perfluorocarbons are a synthetic class of small molecules composed of linear or 
cyclic carbon backbones in which the carbon atoms have been fully substituted with 
fluorine or other halogens(154, 155). These compounds were originally developed during 
the Manhattan Project for use as insulators in nuclear piles(141, 154). Perfluorocarbons 
also serve as the building blocks of products such as Teflon (polytetrafluoroethylene; 
DuPont, Wilmington, DE) and Scotchgard (fluorochemical products; 3M, St. Paul, 
MN)(141, 154). During the 1950’s and 1960’s there was a great deal of research involving 
PFCs which ultimately culminated in the above-mentioned Teflon. During this research it 
was surreptitiously noted that PFCs were able to dissolve vast amounts of non-polar gases 
such as oxygen, carbon dioxide, and nitrogen(117).  Unlike hemoglobin, which carries 
oxygen by binding it to the ferrous center in the heme moiety, PFCs carry oxygen 
passively(147, 154). Perfluorocarbons dissolve oxygen in proportion to the pO2 to which 
they are exposed(147, 154). Therefore the more the pO2 can be increased, the more oxygen 
can be carried(147, 154). Many PFCs in their pure liquid form can dissolve 50-60 mL of 
oxygen per 100 mL of PFC at a pO2 of 760 mmHg (See table 6)(147). 
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Table 6: Oxygen solubility of various perfluorochemicals(49). 
 
Compound O2 Solubility (mL O2/100 mL of 
compound at PO2 760 mmHg) 
Perfluorodihexyl ether 55.42 
Perfluorodibutyl sulfur tetrafluoride 48.02 
Perfluorotriisobutylamine 44.37 
Perfluoro-(N-ethylmorpholine) 50.10 
Perfluoro-N,N-dipropylmethylamine 52.60 
Perfluorotriethylamine 53.86 
Perfluoro-N-methylpiperidine 41.33 
Perfluoro-N-methylmorpholine 37.57 
Perfluoro-N,N-dimethyl-N-hexylamine 51.51 
Perfluoro-N-butylmorpholine 50.59 
Perfluoro-4-(N,N-dimethyl-2-aminoethyl)-morpholine 45.07 
Perfluoropentyl ether 49.67 
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The medical world quickly picked up on this observation and in 1966 it was first 
demonstrated that a PFC liquid could be used to supply oxygen in organ perfusion 
models(51). In the mid-to-late 1970’s experimental work began on liquid breathing 
systems(21). Goldfish, mice, rats, and even cats were submerged in different liquid 
environments(21). Mice and goldfish were placed in low-viscosity silicone oils with 
oxygen solubilities approximately 1.5 times the oxygen content of whole blood(21). Mice 
were able to survive in this environment, but only if the temperature was kept below 18 °C, 
and they all died within 10 minutes of being removed from the oil(21). Goldfish were able 
to survive for weeks in silicone oils bubbled with oxygen(21). Perfluorocarbons proved to 
be a much more satisfactory medium for liquid breathing. An oxygen electrode placed in 
the brain of a mouse prior to immersion showed the same level of tissue oxygenation while 
breathing oxygenated perfluorobutyltetrahydrofurans as when breathing room air(21). 
After removal from the PFC the mice could survive for weeks(21).  
Perfluorocarbon Emulsions 
Around the same time, pure PFCs were being emulsified for possible use as ‘blood 
substitutes’. Several emulsions were developed using the PFCs perfluorotributylamine and 
perfluorodecalin(48). It was found that these emulsions, when properly prepared, could be 
used to perform a total blood volume exchange in rats, reducing their hematocrit below 
1%, and that these rats could survive for weeks after such transfusions(48). These so-called 
‘bloodless’ rats were found to be able to carry out their normal functions, regenerate 
normal blood cells and plasma proteins, and grow and develop normally(48). It was 
believed at the time that such rats could prove to be powerful research tools(116, 129-131, 
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140, 159). At least initially, they were lacking all plasma proteins, and thus any desired 
combination of plasma proteins could be generated simply by adding them to the rat(116, 
129-131, 140, 159). Such models have been used sporadically to study various conditions 
such as cyanide toxicity, carbon monoxide toxicity, transcapillary transport, as well as in 
imaging studies where the refractive effects of haemoglobin need to be eliminated(116, 
129-131, 140, 159). 
Thus far only a single PFC emulsion has been approved by the FDA for use in 
humans, the first-generation PFC emulsion Fluosol-DA(20%) (Green Cross Corp, Osaka, 
Japan), and then only for the prevention or treatment of distal myocardial ischemia during 
coronary angioplasty(147). Although it was fairly successful in this application, its use was 
cumbersome. The development of angioplasty systems which allow coronary flow to 
continue, combined with a side effect profile which included complement release and 
activation, hypotension, white cell depression, and uptake by the reticuloendothelial 
system resulting in hepatomegaly and splenomegaly resulted in Fluosol-DA(20%) never 
gaining enough popularity among clinicians for widespread use(29, 90, 91, 147). 
Ultimately it was withdrawn from the market. Newer second- and third-generation PFC 
emulsions are currently under development. These products contain higher concentrations 
of PFCs, smaller particle sizes, and different emulsifiers which do not provoke such 
aggressive immune responses(147). The PFC emulsions currently under development 
provoke mild flu-like symptoms such as malaise, muscle aches, and a mild fever, as well 
as transient thrombocytopenia 3-4 days after administration of the PFC emulsion(19, 52, 
141, 145, 146, 155). However these mild side-effects are quite tolerable, especially in the 
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light of the much-improved oxygen carrying capacity of these newer products(19, 52, 141, 
145, 146, 155). 
Perfluorocarbons and Decompression Sickness 
PFC emulsions have the ability to enhance the transport of gases other than oxygen. 
All non-polar gases are soluble in PFCs and of particular interest is nitrogen. In pure PFCs 
nitrogen may be up to 10,000 times more soluble than in plasma(147). Nitrogen is the 
primary component of room air and as such can become a problem in many surgical 
procedures. Microscopic air emboli are a common problem in cardiopulmonary bypass, 
and larger air emboli are serious complications of neurosurgical, orthopaedic, and some 
gynaecological procedures(17, 53, 85, 120, 126). Animal studies have shown that PFC 
emulsions administered preoperatively can greatly reduce, or prevent entirely, the harmful 
effects of venous air embolism, intracoronary air embolism, and cerebral arterial gas 
embolism(110, 149, 150, 162). Data obtained using early formulations of PFC emulsions 
suggests strongly that the capacity of the PFC emulsion to dissolve and carry nitrogen is 
one of the likely mechanisms by which this protection is afforded(110, 149, 150, 162).  
It is the ability of PFC emulsions to dissolve and remove larger amounts of nitrogen 
that first attracted attention in the realm of DCS research. Since excess nitrogen trapped in 
tissue is believed to be the root cause of DCS, a therapy which could either act as a sink for 
that nitrogen, increasing the effective volume of distribution sufficiently that bubbling is 
limited, or that can speed the elimination of excess nitrogen from the body, again, limiting 
bubble formation and growth, is an obvious target for DCS research. The use of PFCs for 
the prevention or treatment of DCS has taken many different forms. Likely the most 
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esoteric of these was the enteric administration of pure, degassed PFCs(142). Although this 
idea was patented over 12 years ago, there has been no active research on this topic since. 
Far more common is the idea that either I.V. PFC emulsions or pure, oxygenated PFC 
liquids as breathing media can be used to treat or prevent DCS. The ideal situation is to 
prevent DCS altogether. Several studies have demonstrated that breathing liquid, 
oxygenated PFCs during hyperbaric exposures followed by rapid or even explosive 
decompression is able to prevent the development of DCS, while air-breathing control 
animals exposed to the same compression/decompression produced large numbers of 
animals with severe DCS(50, 89, 103, 175). Diving performed using liquid breathing 
would most likely make DCS irrelevant, but there are enormous hurdles which would need 
to be overcome. The respiratory muscles are not designed to move a high-viscosity liquid 
in and out of the lungs and would quickly be exhausted by doing so. This would 
necessitate a closed-circuit ventilator capable of pumping the PFC in and out of the lungs, 
as well as adding oxygen to, and removing carbon dioxide from the breathing liquid. There 
are also tremendous psychological factors which would need to be overcome. Inhaling a 
liquid causes a sensation of drowning and produces panic(2, 11). These factors combine to 
make what may be an ideal solution to the problem very impractical. 
Research has instead focused primarily on the I.V. use of PFC emulsions to treat or 
prevent DCS. Lundgren et al. demonstrated that I.V. PFC emulsions could greatly enhance 
nitrogen washout at surface pressure while breathing oxygen(99). Although no 
compression/decompression was associated with this experiment, it demonstrated that I.V. 
PFC emulsions might be able to prevent DCS when used prophylactically to remove the 
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nitrogen normally present in the body prior to a dive. Unfortunately this sort of treatment is 
unlikely to be useful in the real world. Mahon et al. found that although I.V. PFCs 
administered at depth enhanced nitrogen elimination, they also enhanced acute oxygen 
toxicity manifested by seizure activity(104). Since acute oxygen toxicity is of much greater 
immediate danger to a diver in the water, I.V. PFC emulsions are unlikely to be 
administered before a diver has left the water.  
Intravenous PFC emulsions used after exit from the water in order to treat DCS, 
rather than to prevent it, appear much more likely to be clinically useful. Several studies 
have demonstrated that the administration of I.V. PFC emulsions after the onset of severe 
DCS is able to dramatically reduce morbidity and mortality in a variety of species(23, 31, 
100, 151). That the administration of I.V. PFC emulsions can reduce both the severity of 
DCS symptoms and reduce the lethality of severe DCS is now generally accepted within 
the hyperbaric community, but the mechanism of this protective effect has not yet been 
demonstrated.  
The studies described in this dissertation were purposed to examine two possible 
mechanisms for the protective effects afforded by I.V. PFC administration in severe 
cardiopulmonary DCS: First, that the intravenous administration of PFC emulsions acutely 
following decompression is able to increase oxygen delivery at the whole-body level, and 
presumably to prevent or lessen hypoxic death or injury of tissue to which there is little or 
no blood flow as a result of bubble obstruction. Second, that the intravenous administration 
of PFC emulsions acutely following decompression is able to increase the removal of 
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excess nitrogen from the body, thus relieving the obstructions caused by intravascular gas 
bubbles.
CHAPTER 2 
INTRAVENOUS PERFLUOROCARBON EMULSIONS INCREASE 
WHOLE-BODY OXYGENATION AFTER SEVERE 
DECOMPRESSION SICKNESS 
 
Introduction 
Breathing compressed air increases the amount of nitrogen dissolved in body 
fluids(54, 112, 135). Factors such as depth, thus the ambient pressure, and the duration of 
the dive are the primary determinants of the amount of excess nitrogen absorbed(26, 54, 
112, 135). As a diver ascends and ambient pressure decreases it is possible for the 
dissolved gas tensions in tissue to exceed ambient pressure. This supersaturated state leads 
to the formation and growth of free gas bubbles, resulting in venous gas emboli (VGE) and 
possible arterial gas emboli (AGE)(26, 32). It is believed that these bubbles within the 
vasculature are the root cause of decompression sickness (DCS)(26, 32). There are likely 
multiple pathophysiological mechanisms at play in DCS including impairment of 
microcirculation by inert gas bubbles, increased blood viscosity, damage to endothelium, 
and activation of complement. The physiochemical discontinuity of the gas-blood interface 
can also denature proteins promoting the release of fatty acids from cell membranes 
leading to the formation of fat emboli(26, 32). When intravascular bubbles obstruct 
capillaries or venules, it often leads to ischemia followed by reperfusion induced oxidative 
tissue damage(37).  
 Perfluorocarbon emulsions (PFCs) are intravenous emulsions of fluoridated 
hydrocarbons within phospholipid micro-particle micelles(155). PFCs have been 
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developed in medicine as intravenous oxygen therapeutics(155). PFCs accomplish this in a 
way which is fundamentally different from how whole blood transports the majority of its 
oxygen content. Oxygen, or any other gas, carried by PFCs is not bound, as oxygen is to 
hemoglobin, rather it is dissolved in the PFC itself. PFC, because of its non-polarity, can 
dissolve up to 60 volume percent oxygen(117). Plasma can only dissolve 0.034 volume 
percent but whole blood at 14 gm/dl hemoglobin can chemically bind up to 21 volume 
percent oxygen. The oxygen dissolved in PFC is all available for tissue usage whereas that 
chemically bound by hemoglobin is restricted (usually only 23% can be released for 
metabolism). Microcirculatory changes such as edema, vasospasm, white cell activation 
and vessel plugging result in decreased erythrocyte delivery of oxygen to watershed 
neurons, yet plasma flow may continue without red cells(160). PFC, due to its extremely 
small particle size (~0.1-0.4 µm) can be delivered in this trickle-flow of plasma(9, 137, 
155). Plasma flow oxygen delivery by PFCs is enough to keep tissue alive, as seen with 
Fluosol DA-20%, a first generation PFC which reduced myocardial infarction and 
garnered FDA approval(86, 87). 
PFC is also effective in treating DCS, AGE and VGE(23, 31, 147-149, 151, 196). 
Using a saturation dive model with direct ascent to the surface, Dromsky et al. found that 
the administration of I.V. PFC while breathing 95% oxygen was able to decrease the 
lethality of this decompression insult, decrease the incidence of DCS, and decrease the 
number of neurological events(31). Similarly it was found that I.V. PFC can improve 
outcomes after massive VGE, cerebral AGE, and coronary AGE(148-150). The 
administration of I.V. PFC has also been shown to increase nitrogen washout through the 
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lungs after VGE(196). Clearly PFC administration is of benefit in the treatment of 
decompression illnesses, but the exact mechanism of this benefit has not yet been 
elucidated. Is this benefit a result of the PFCs ability to increase nitrogen washout, and 
thus, presumably, to remove the bubbles obstructing circulation faster? Is it a product of 
improving the oxygen supply and thus metabolic state of tissue to which blood flow and 
oxygen supply has been disturbed? Is it some combination of both of these events? The 
research described here was designed to investigate the effect of I.V. PFC emulsions 
administered acutely after surfacing on whole-body oxygenation in an ovine model of 
severe DCS. 
 
Materials and Methods 
All animal experiments performed for this project were done in strict accordance 
with the National Institutes of Health (NIH) “Guide for the Care and Use of Laboratory 
Animals” and were approved by both the Department of Defense (DoD) and the Virginia 
Commonwealth University Institutional Animal Care and Use Committee (IACUC). 
Juvenile Dorper cross sheep of either sex (Robinson Services, Inc., Mocksville, NC) 
weighing 14-24 kg were housed in United States Department of Agriculture (USDA)- and 
Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALAC)-approved facilities in social flocks with free access to food and water on a 12-
hour light/dark cycle. Sheep were allowed a minimum of 3 days for acclimatization and 
veterinary inspection prior to their use in any experiment. 
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Sheep Instrumentation and Preparation 
Prior to the experiment sheep were muzzled for a period of 48 hours in order to 
prevent access to food and providing free access to water while remaining with the 
remainder of their flock in order to limit animal stress. Sheep were initially sedated with 
ketamine/xylazine (20.0/2.0 mg/kg I.M.) and the animal was placed supine on the surgical 
table. All animals were promptly intubated with a 9.0 mm internal diameter (I.D.) cuffed 
endotracheal tube (Hudson RCI, Temecula, CA) and ventilated with 50/50 
nitrogen/oxygen using a Siemens 900C servo ventilator (Siemens Corp., New York, NY) 
set to a tidal volume of approximately 10 mL/kg adjusted to maintain arterial pCO2 at 40 
mmHg ± 5 mmHg. An orogastric tube fashioned from TYGON® R-3603 tubing (Satin-
Gobain Performance Plastics Corp., Akron, OH) was advanced into the rumen to allow for 
fluid drainage and to allow gas accumulated in the gut during the air dive to vent upon 
decompression. A MAC® 2-port introducer sheath (Arrow International Inc., Reading, PA) 
was placed in the right external jugular vein to allow for the administration of fluids and 
the anesthetic cocktail. Once I.V. access was secured, administration of the triple drip 
anesthetic cocktail (ketamine/xylazine/guaifenesin 2.0/0.1/50.0 mg/mL in 5% dextrose) 
was begun immediately at 1.0-2.0 mL/kg/hr titrated to maintain a surgical plane of 
anesthesia using a Harvard Apparatus PHD 2000 programmable syringe pump (Harvard 
Apparatus, Holliston, MA). The right femoral artery was canulated with an 18 gauge (G) 
femoral arterial catheter (Arrow International Inc., Reading, PA) for monitoring of arterial 
pressure (AP) and arterial blood sampling. The right femoral vein was canulated with a 4 
French (Fr) double lumen catheter (Arrow International Inc., Reading, PA) for the 
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administration of the anesthetic cocktail while inside the hyperbaric chamber and for the 
administration of the treatment drug after exiting the hyperbaric chamber. The left femoral 
vein was canulated for the placement of a 7.5 Fr CCOmbo® continuous cardiac output 
(CCO) pulmonary artery catheter to allow for CCO monitoring, central venous (CVP) and 
pulmonary arterial pressure (PAP) monitoring, and central venous blood sampling. 
Respiratory gases were continuously monitored using an MGA 1100 respiratory mass 
spectrometer (Perkin-Elmer, Norwalk, CT). Following surgical manipulations all animals 
were allowed to stabilize for a minimum of 30 minutes. After stabilization animals were 
weaned off the ventilator until capable of spontaneously breathing prior to being placed 
inside the hyperbaric chamber. 
Inclusion/Exclusion Criteria 
At the end of the stabilization period all animals were required to meet certain 
inclusion criteria prior to being weaned off the ventilator and placed in the hyperbaric 
chamber. The inclusion criteria were as follows: mean arterial pressure above 60 mmHg, 
arterial pO2 above 200 mmHg, arterial pH 7.45 ± 5, arterial pCO2 40 ± 5 mmHg. All 
animals not meeting the above inclusion criteria were excluded from the study and 
euthanized. 
Sheep Dry Dive Procedures 
All sheep that met the study inclusion criteria (n=31) were weaned off the ventilator 
until capable of breathing spontaneously, then disconnected from all monitoring equipment 
and placed into a Reimers Systems model #17-48-100 Research Hyperbaric Chamber 
(Reimers Systems, Inc., Springfield, VA). During the dry dive procedures all animals 
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breathed room air and general anesthesia was maintained using a continuous infusion of 
triple drip as described above. All sheep were subjected to the following dive profile: 
Beginning at 1.0 ATA the chamber was compressed at a rate of 1.0 ATA/minute to a 
pressure of 2.0 ATA. From 2.0 ATA the chamber was compressed at a rate of 2.0 
ATA/minute to a pressure of 6.0 ATA (165 feet of seawater (fsw), or 608 kilopascals 
(kPa)). The pressure of 6.0 ATA was maintained for 27 minutes, after which sheep were 
immediately decompressed to 1.0 ATA at a rate of 2.0 ATA/minute. 
Post-Decompression Monitoring 
Upon complete decompression (considered time=0) all animals were quickly 
removed from the hyperbaric chamber and all monitoring equipment was reconnected. At 
this point animals were randomized to receive I.V. infusion of either 6.0 mL/kg Oxycyte® 
PFC (n=15) (Synthetic Blood International, Costa Mesa, CA) or saline control (n=16) and 
one of four breathing gases; 100% oxygen (n=8), 80/20% nitrogen/oxygen (n=8), 50/50% 
helium/oxygen (n=7), or 80/20% helium oxygen (n=8). Animals were randomized using a 
block randomization scheme such that for every 8 experiments performed one animal fell 
into each of the 8 treatment groups, but the order within each block was random. 
Neuromuscular blockade with I.V. pancuronium (0.1 mg/kg) given acutely post-chamber 
was necessary in order to accurately measure respiratory gases with the mass spectrometer. 
All animals were monitored for 90 minutes after decompression, during which time both 
arterial and mixed venous blood samples were drawn and analyzed using a Radiometer 
OSM 3 Hemoximeter and a radiometer ABL 700 blood gas analyzer (Radiometer America, 
Westlake, OH) at 5, 10, 15, 30, 60 and 90 minutes after decompression. Data from all 
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instruments was recorded directly to hard drive storage using the BioPac system and 
Acqknowledge v. 3.90 software (BioPac Systems, Inc. Goleta, CA) After 90 minutes all 
animals were euthanized. 
Later offline analyses were performed in order to determine arterial and mixed 
venous blood oxygen content ( , 2aC O 2vC O ), oxygen delivery ( ), tissue oxygen 
consumption ( ), and oxygen extraction ratio (ER). The following formulae were used 
for the calculations: 
2DO
2VO
Arterial oxygen content:  
2 2 2 2(1.34 ) [(0.0031 ) (0.01997 )]a a a aC O Hb S O P O P Oα β= × × + × × + × ×    (1) 
Mixed venous oxygen content: 
2 2 2 2(1.34 ) [(0.0031 ) (0.01997 )]v v v vC O Hb S O P O P Oα β= × × + × × + × ×    (2) 
 
Oxygen delivery: 
2
2
[ ( 10)]aCO C ODO
weight
× ×=     (3) 
 
Oxygen consumption: 
2 2
2
[( ) 10]a vCO C O C OVO
weight
× − ×=     (4) 
Extraction ratio: 
2
2
VOER
DO
=      (5) 
 
Where  = arterial oxygen content in mL/dL 2aC O
 2vC O  = mixed venous oxygen content in mL/dL 
 Hb = hemoglobin concentration in mg/dL 
  = arterial oxygen saturation fraction 2aS O
  = arterial oxygen tension in mmHg 2aP O
  = oxygen delivery in L/minute/kg body weight 2DO
  = oxygen consumption in L/minute/kg body weight 2VO
 ER = extraction ratio 
 CO = cardiac output in L/minute 
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 0.0031 = oxygen solubility coefficient in plasma in mL/dL 
0.01997 = oxygen solubility coefficient in PFC in mL/dL 
α = blood fraction of circulation volume 
 β = PFC fraction of circulating volume 
 
Statistical Methods 
Unless otherwise stated all data were analyzed using repeated-measures analysis of 
variance (ANOVA) controlling for cardiac index, PFC administration, and breathing gas 
administered, followed by Least Squares Means Student’s t-test, as appropriate, to 
determine if treatment and control groups were significantly different. Data are presented 
as Least Squares Means ± Standard Error. Differences considered statistically significant 
with p-values of less than 0.05. All statistical calculations were performed using the 
statistical software JMP 7 from SAS Institute (Cary, NC). 
 
Results 
One-way ANOVA performed on baseline data obtained during the stabilization 
period post surgery and pre-dive, controlling for breathing gas, indicated that there were no 
statistically significant differences between the PFC-treated group and the saline controls 
on any of the variables of interest (PFC vs. saline - cardiac index (indexed to body 
weight)(CI): 91.88 ± 0.65 vs. 100.84 ± 0.63 mL/minute/kg, p=0.3305; : 15.72 ± 0.53 
vs. 14.67 ± 0.51 mL/dL, p=0.1680; 
2aC O
2vC O : 12.28 ± 0.48 vs. 10.95 ± 0.47 mL/dL, p=0.0610; 
: 14.35 ± 0.90 vs. 14.65 ± 0.87 mL/minute/kg, p=0.8097; : 3.09 ± 0.34 vs. 3.71 ± 
0.33 mL/minute/kg, p=0.1931; ER: 0.22 ±0.019 vs. 0.25 ± 0.019, p=0.2895). 
2DO 2VO
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After compression/decompression it was found that, with regards to CI, the 
repeated measures ANOVA was significant as a whole model (F=14.91, df=5, p<0.0001) 
as well as with regards to perfluorocarbon administration (F=17.99, df=1, p<0.0001) and 
with regards to time (F=7.06, df=1, p=0.0087). Using Student’s t-test cardiac index was 
found to decrease over the course of the experiment and it was found to be significantly 
lower in the PFC-treated group vs. the saline control group (82.66 ± 3.46 vs. 102.61 ± 3.18 
mL/minute/kg, p<0.0001 – see figure 3). Due to the significant effect PFC administration 
had on CI, CI was controlled for in all further analyses.  
The analysis of arterial oxygen content, as a whole model, was found to be 
significant (F=10.89, df=6, p<0.0001). This model was also found to be significant with 
respect to PFC administration (F=17.31, df=1, p<0.0001) and with respect to time (F=8.61, 
df=1, p=0.0038). Using Student’s t-test It was found that was significantly higher in 
the PFC-treated group vs. the saline group (16.30 ± 0.27 vs. 14.75 ± 0.25 mL/dL, 
p<0.0001) and increased over the course of the experiment – see figure 4. 
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With regard to mixed venous oxygen content, it was found that the whole model 
was significant (F=7.68, df=6, p<0.0001), but neither PFC administration (F=3.71, df=1, 
p=0.0558) nor time (F=1.16, df=1, p=0.2822) had a significant effect. Student’s t-test 
indicated that 2vC O was not significantly different in the PFC-treated group vs. the saline 
control group (12.45 ± 0.26 vs. 11.74 ± 0.24 mL/dL, p=0.0558) – see figure 5. 
With regards to , it was found that the whole model was significant (F=104.27, 
df=6, p<0.0001) and that PFC administration had a significant effect (F=12.97, df=1, 
2DO
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p=0.0004), but time did not (F=3.46, df=1, p=0.0648). Student’s t-test showed that the 
effect of the PFC was to increase over the saline control group (14.83 ± 0.28 vs. 13.44 
± 0.25 mL/minute/kg, p=0.0004) – see figure 6. 
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Similar effects were observed with regard to . The whole model was significant 
(F=26.22, df=6, p<0.0001), and both PFC (F=10.11, df=1, p=0.0018) and time (F=9.13, 
df=1, p=0.0029) were observed to have significant effects. Student’s t-test showed that 
PFC increased vs. saline control (3.37 ± 0.14 vs. 2.76 ± 0.13 mL/minute/kg, 
p=0.0018) and was found to increase over the course of the experiment – see figure 7. 
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When extraction ratio, defined as 2
2
VO
DO

 , was analyzed it was found that the 
whole model was significant (F=4.94, df=6, p<0.0001). The effect of PFC was found not 
to be statistically significant (F=1.76, df=1, p=0.1869) while the effect of time was 
significant (F=5.85, df=1, p=0.0167). PFC administration did not significantly increase the 
ER over saline control (0.23 ± 0.012 vs. 0.21 ± 0.011, p=0.1869), but ER did increase over 
the course of the experiment – see figure 8. 
Discussion and Conclusions 
As has been seen before in other split-hoofed animal models, I.V. administration of 
PFCs resulted in decreased CI in this model(152). In the previous work conducted in pigs, 
pulmonary hypertension was reported to be the cause of the observed decrease in CI and 
similar observations were made here(152). When analysed using the same repeated 
measures ANOVA model described above pulmonary arterial pressure was found to be 
nearly doubled in the PFC-treated animals vs. the saline control (27.10 ± 1.12 vs. 15.50 ± 
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1.12, p<0.0001). This suggests that the problem of pulmonary hypertension leading to 
decreased CI will likely be present in all split-hoofed species.  
It is clear from this study that I.V. PFC administration results in an increase in 
CaO2. In the PFC-treated group arterial oxygen content is elevated nearly 11% over 
control. Even if the oxygen carried directly by the PFC is removed from the calculations, 
arterial oxygen content is still significantly higher in the PFC-treated vs. the saline-treated 
group (15.87 ± 0.26 vs. 14.73 ± 0.24 mL/dL, p=0.0019), so it would appear that PFC does 
more than simply carry more oxygen. Exactly what PFC is doing, in addition to its own 
nascent oxygen carrying ability, is unclear. Further analysis using the repeated measures 
ANOVA model showed both PaO2 and SaO2 were significantly lower in the PFC-treated 
vs. saline-treated group (200.03 ± 10.77 vs. 238.72 ± 9.90 mmHg, p=0.0109 and 93.52 ± 
0.89 vs. 97.39 ± 0.81 %, p=0.0021, respectively). Hemoglobin (Hb) was elevated in the 
PFC-treated group vs. the saline control after compression/decompression (12.22 ± 0.17 
vs. 10.72 ± 0.15 mg/dL, p<0.0001) but not when baseline results were analysed using one-
way ANOVA (11.19 ± 0.38 vs. 10.61 ± 0.37 mg/dL, p=0.2931). It is possible that the 
presence of the PFC is inducing the release of erythrocytes from the spleen or other 
storage, accounting for the higher Hb, and thus the higher CaO2 in the PFC-treated group. 
Likewise, the observation that PFC administration results in increases in both 
and of 10% and 22%, respectively, demonstrates that the PFC is able to not only 
increase the amount of oxygen present in the blood, but is able to improve tissue access to 
that oxygen. This suggests that the mechanism of I.V. PFC improving tissue oxygenation 
is not simply its ability to dissolve and carry greater quantities of oxygen, but that it 
2DO 2VO
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facilitates oxygen delivery to cells. This may take the form of the PFC extravasating in 
capillary beds, taking dissolved oxygen with it. Alternatively the PFC emulsion particles, 
being approximately 1/100th - 1/1000th the size of an erythrocyte, may be able to pass 
through blood vessels where red cell flow has been blocked by bubbles, but a trickle flow 
of plasma remains(31, 151) – see figures 9 and 10. In this case the small amount of oxygen 
carried in the PFC may be sufficient to keep tissue viable which otherwise might succumb 
to hypoxic injury. More interestingly, PFC particles may act as a bridge, of sorts, 
facilitating the movement of oxygen from erythrocytes out into cells where it is needed. 
This possibility has very intriguing implications. As shown above, the amount of oxygen 
actually dissolved in PFC is relatively small. Hemoglobin binding oxygen remains the 
dominant mechanism for oxygen transport. Once in capillary beds the greatest impediment 
to oxygen offloading from hemoglobin into tissue is the plasma(133). Oxygen is very 
insoluble in plasma, and much more soluble in PFC. In this case the PFC would act almost 
as a transport vessel for oxygen, ferrying it from erythrocytes to tissue, a mechanism 
somewhat akin to facilitated diffusion across cell membranes. These possible mechanisms 
should be explored further in future studies.  
It is clear from these results that improved tissue oxygenation at a whole-body level 
is likely responsible for at least a portion of the beneficial effects offered by the I.V. 
administration of PFC emulsions after severe decompression sickness. 
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Figure 3: The effect of perfluorocarbon administration on cardiac index. 
 
The effect of the administration of PFC emulsions, when the effects of time and 
breathing gas are controlled for, is to significantly decrease cardiac index vs. the saline 
control group (82.66 ± 3.46 vs. 102.61 ± 3.18 mL/minute/kg, p<0.0001).  
 
57 
 
0
5
10
15
20
25
0 10 20 30 40 50 60 70 80 90 100
Time (min)
A
rt
er
ia
l O
xy
ge
n 
C
on
te
nt
 (m
L/
dL
)  
   
   
 g
PFC
Saline
PFC Saline
0.0
2.5
5.0
7.5
10.0
12.5
15.0
17.5
PFC
Saline
*
* p<0.0001
C
aO
2
(m
L/
dL
)
 
Figure 4: The effect of perfluorocarbon administration on arterial oxygen content. 
 
The effect of the administration of PFC emulsions, when the effects of time, 
breathing gas, and CI are controlled for, is to significantly increase  vs. the saline 
control group (16.30 ± 0.27 vs. 14.75 ± 0.25 mL/dL, p<0.0001).  
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Figure 5: The effect of perfluorocarbon administration on mixed venous oxygen 
content. 
 
When the effects of time, breathing gas, and CI are controlled for, PFC has no 
significant effect on 2vC O vs. the saline control group (12.45 ± 0.26 vs. 11.74 ± 0.24 
mL/dL, p=0.0558). 
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Figure 6: The effect of perfluorocarbon administration on oxygen delivery. 
 
The effect of the administration of PFC emulsions, when the effects of time, 
breathing gas, and CI are controlled for, is to significantly increase 2 vs. the saline 
control group (14.83 ± 0.28 vs. 13.44 ± 0.25 mL/minute/kg, p=0.0004).  
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Figure 7: The effect of perfluorocarbon administration on oxygen consumption. 
vs. the saline 
control group (3.37 ± 0.14 vs. 2.76 ± 0.13 mL/kg/minute, p=0.0018). 
 
The effect of the administration of PFC emulsions, when the effects of time, 
breathing gas, and CI are controlled for, is to significantly increase VO 2
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Figure 8: The effect of perfluorocarbon administration on extraction ratio. 
 
When the effects of time, breathing gas, and CI are controlled for, PFC has no 
significant effect on ER vs. the saline control group (0.23 ± 0.012 vs. 0.21 ± 0.011, 
p=0.1869).  
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Figure 9: Erythrocyte size compared with PFC emulsion particle size. 
 
A cartoon illustrating the relative size of red blood cells (diameter approx 6-8 μm) 
compared to Oxycyte® PFC emulsion particle size (approx 0.1-04 μm). 
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Figure 10: Perfluorocarbon emulsion particles can pass thrombi which block blood 
flow. 
 
A cartoon illustrating that PFC emulsion particles, due to their small size (approx 
0.1-0.4 μm), are able to flow past emboli such as bubbles, fat, blood clots, and 
constrictions which obstruct the flow of erythrocytes. By moving past such obstructions 
PFCs may be able to continue to deliver enough oxygen to tissues with no red cell flow to 
stave off hypoxic injury or death. 
CHAPTER 3 
INTRAVENOUS PERFLUOROCARBON EMULSIONS INCREASE 
THE EXTENT, BUT NOT THE RATE WHILE HELIUM-OXYGEN 
BREATHING INCREASES THE RATE, BUT NOT THE EXTENT OF 
NITROGEN WASHOUT AFTER SEVERE DECOMPRESSION 
SICKNESS 
 
Introduction 
Breathing compressed air increases the amount of nitrogen dissolved in body 
fluids(54, 112, 135). Factors such as depth, and thus the ambient pressure, and the duration 
of the dive are the primary determinants of the amount of excess nitrogen absorbed(26, 54, 
112, 135). As a diver ascends and ambient pressure decreases, it is possible for the 
dissolved gas tensions in tissue to exceed ambient pressure. This supersaturated state leads 
to the formation and growth of free gas bubbles resulting in venous gas emboli (VGE) and 
possible arterial gas emboli (AGE)(26, 32). It is believed that these bubbles within the 
vasculature are the root cause of decompression sickness (DCS)(26, 32). There are likely 
multiple pathophysiologic mechanisms at play in DCS including impairment of 
microcirculation by inert gas bubbles, increased blood viscosity, damage to endothelium, 
and activation of complement. The physiochemical discontinuity of the gas-blood interface 
can also denature proteins promoting the release of fatty acids from cell membranes 
leading to the formation of fat emboli(26, 32). When intravascular bubbles obstruct 
capillaries or venules, it often leads to ischemia followed by reperfusion oxidative tissue 
damage(37).  
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 Perfluorocarbon emulsions (PFCs) are intravenous (I.V.) emulsions of fluoridated 
hydrocarbons within phospholipid micro-particle micelles(155). PFCs have been 
developed in medicine as intravenous oxygen therapeutics(155). PFCs accomplish this in a 
way which is fundamentally different from how whole blood transports the majority of its 
oxygen content. Oxygen, or any other gas, carried by PFCs is not bound as oxygen is to 
hemoglobin, rather it is dissolved in the PFC itself. PFC, because of its non-polarity, can 
dissolve up to 60 volume percent oxygen(117). Plasma can only dissolve 0.034 volume 
percent oxygen, but whole blood at 14 gm/dl hemoglobin can chemically bind up to 21 
volume percent oxygen. The oxygen dissolved in PFC is all available for tissue usage 
whereas oxygen chemically bound by hemoglobin is restricted (usually only 23% can be 
released for metabolism). Microcirculatory changes such as edema, vasospasm, white cell 
activation and vessel plugging result in decreased erythrocyte delivery of oxygen to 
watershed neurons, yet plasma flow continues without red cells(160). PFC, due to its 
extremely small particle size (~0.1-0.4 µm) can be delivered in this trickle-flow of 
plasma(9, 137, 155). Plasma flow oxygen delivery by PFCs is enough to keep tissue alive, 
as seen with Fluosol DA-20%, a first generation PFC which reduced myocardial infarction 
and garnered FDA approval(86, 87). 
PFC is also effective in treating DCS, AGE and VGE(23, 31, 147-149, 151, 196). 
Using a saturation dive model with direct ascent to the surface, Dromsky et al. found that 
the administration of I.V. PFC while breathing 95% oxygen was able to decrease the 
lethality of this decompression insult, decrease the incidence of DCS, and decrease the 
number of neurological events(31). Similarly it has been found that I.V. PFC can improve 
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outcomes after massive VGE, cerebral AGE, and coronary AGE(148-150). The 
administration of I.V. PFC has also been shown to increase nitrogen washout through the 
lungs after venous air embolism(196). Clearly PFC administration is of benefit in the 
treatment of decompression illnesses, but the exact mechanism of this benefit has not yet 
been elucidated. Is this benefit a result of the PFCs ability to increase nitrogen washout, 
and thus, presumably, to remove the bubbles obstructing circulation faster? Is it a product 
of improving the oxygen supply and thus metabolic state of tissue to which blood flow and 
oxygen supply has been disturbed? Is it some combination of these two processes?  
Helium-based breathing mixes also offer an interesting and relatively unexplored 
avenue of investigation. It is well understood that helium-based breathing gases improve 
ventilation and clinical condition in asthma and chronic obstructive pulmonary disease 
(COPD) patients(44, 139, 143). This improvement is a product of the physical properties 
of helium(43). Helium is approximately an order of magnitude less dense than either 
oxygen or nitrogen and helium-oxygen (HeO2) mixtures are always less dense than 
nitrogen-oxygen mixtures(43). Inhaling HeO2 mixtures alters ventilatory mechanics by 
modifying gas convection in the airways thus increasing alveolar ventilation(28, 30, 43). 
The dramatically decreased density of HeO2 mixtures compared to nitrogen-oxygen 
mixtures results in airflow through conducting airways being much less turbulent(28, 30, 
43, 124, 184). This laminar flow, in turn, results in less airway resistance and a much 
smaller pressure gradient being required to move gas through the tracheo-bronchial 
tree(28, 30, 43, 124, 184). Clinically this reduces the work of breathing and improves 
oxygen delivery to the alveoli(28, 30, 43, 124, 184). These improvements have been 
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observed not only in spontaneously breathing patients, but also in patients receiving both 
non-invasive positive pressure ventilation and mechanical ventilation(42, 83, 84, 94). 
The research described here was designed to investigate the effect of I.V. PFC 
emulsions and helium-based breathing mixtures, both administered acutely after surfacing, 
on nitrogen washout in an ovine model of severe DCS. 
 
Materials and Methods 
This study was performed in conjunction with the whole-body oxygenation study 
described above in chapter 2. 
All animal experiments performed for this project were done in strict accordance 
with the National Institutes of Health (NIH) “Guide for the Care and Use of Laboratory 
Animals” and were approved by both the Department of Defense (DoD) and the Virginia 
Commonwealth University Institutional Animal Care and Use Committee (IACUC). 
Juvenile Dorper cross sheep of either sex (Robinson Services, Inc., Mocksville, NC) 
weighing 15-20 kg were housed in United States Department of Agriculture (USDA)- and 
Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALAC)-approved facilities in social flocks with free access to food and water on a 12-
hour light/dark cycle. Sheep were allowed a minimum of 3 days for acclimatization and 
veterinary inspection prior to their use in any experiment. 
Sheep Instrumentation and Preparation 
48 hours prior to the experiment, sheep were muzzled to prevent access to food and 
provide free access to water while remaining with the remainder of their flock in order to 
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limit animal stress. Sheep were initially sedated with ketamine/xylazine (20.0/2.0 mg/kg 
I.M.) and the animal was placed supine on the surgical table. All animals were promptly 
intubated with a 9.0 mm internal diameter (I.D.) cuffed endotracheal tube (Hudson RCI, 
Temecula, CA) and ventilated with 50/50 nitrogen/oxygen using a Siemens 900C servo 
ventilator (Siemens Corp., New York, NY) set to a tidal volume of approximately 10 
mL/kg adjusted to maintain arterial pCO2 at 40 mmHg ± 5 mmHg. An orogastric tube 
fashioned from TYGON® R-3603 tubing (Satin-Gobain Performance Plastics Corp., 
Akron, OH) was advanced into the rumen to allow for fluid drainage and to allow gas 
accumulated in the gut during the air dive to vent upon decompression. A MAC® 2-port 
introducer sheath (Arrow International Inc., Reading, PA) was placed in the right external 
jugular vein to allow for the administration of fluids and the anesthetic cocktail. Once I.V. 
access was secured, administration of the triple drip anesthetic cocktail 
(ketamine/xylazine/guaifenesin 2.0/0.1/50.0 mg/mL in 5% dextrose) was begun 
immediately at 1.0-2.0 mL/kg/hr, titrated to maintain a surgical plane of anesthesia using a 
Harvard Apparatus PHD 2000 programmable syringe pump (Harvard Apparatus, 
Holliston, MA). The right femoral artery was canulated with an 18 gauge (G) femoral 
arterial catheter (Arrow International Inc., Reading, PA) for monitoring of arterial pressure 
(AP) and arterial blood sampling. The right femoral vein was canulated with a 4 French 
(Fr) double lumen catheter (Arrow International Inc., Reading, PA) for the administration 
of the anesthetic cocktail while inside the hyperbaric chamber and for the administration of 
the treatment drug after exiting the hyperbaric chamber. The left femoral vein was 
canulated for the placement of a 7.5 Fr CCOmbo® continuous cardiac output (CCO) 
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pulmonary artery catheter to allow for CCO monitoring, central venous (CVP) and 
pulmonary arterial pressure (PAP) monitoring, and central venous blood sampling. 
Respiratory gases were continuously monitored using an MGA 1100 respiratory mass 
spectrometer (Perkin-Elmer, Norwalk, CT). Following surgical manipulations all animals 
were allowed to stabilize for a minimum of 30 minutes. After stabilization animals were 
weaned off the ventilator until capable of spontaneously breathing prior to being placed 
inside the hyperbaric chamber. 
Inclusion/Exclusion Criteria 
At the end of the stabilization period all animals were required to meet certain 
inclusion criteria prior to being weaned off the ventilator and placed in the hyperbaric 
chamber. The inclusion criteria were as follows: mean arterial pressure above 60 mmHg, 
arterial pO2 above 200 mmHg, arterial pH 7.45 ± 5, arterial pCO2 40 ± 5 mmHg. All 
animals not meeting the above inclusion criteria were excluded from the study and 
euthanized. 
Sheep Dry Dive Procedures 
All sheep that met the study inclusion criteria (n=31) were weaned off the ventilator 
until capable of breathing spontaneously, disconnected form all monitoring equipment and 
placed into a Reimers Systems model #17-48-100 Research Hyperbaric Chamber (Reimers 
Systems, Inc., Springfield, VA). During the dry dive procedures all animals breathed room 
air and general anesthesia was maintained using a continuous infusion of triple drip as 
described above. All sheep were subjected to the following dive profile: Beginning at 1.0 
ATA the chamber was compressed at a rate of 1.0 ATA/minute to a pressure of 2.0 ATA. 
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From 2.0 ATA the chamber was compressed at a rate of 2.0 ATA/min to a pressure of 6.0 
ATA (165 feet of seawater (fsw), or 608 kilopascals (kPa)). The pressure of 6.0 ATA was 
maintained for 27 minutes after which sheep were immediately decompressed to 1.0 ATA 
at a rate of 2.0 ATA/minute. 
Post-Decompression Monitoring 
Upon complete decompression (considered time=0) all animals were quickly 
removed from the hyperbaric chamber and all monitoring equipment was reconnected. At 
this point animals were randomized to receive I.V. infusion of either 6.0 mL/kg Oxycyte® 
PFC emulsion (n=15) (Synthetic Blood International, Costa Mesa, CA) or saline control 
(n=16) and one of four breathing gases; 100% oxygen (n=8), 80/20% nitrogen/oxygen 
(n=8), 50/50% helium/oxygen (n=7), or 80/20% helium oxygen (n=8). Animals were 
randomized using a block randomization scheme such that for every 8 experiments 
performed, one animal fell into each of the 8 treatment groups, but the order within each 
block was random. Data from all instruments was recorded directly to hard drive storage 
using the BioPac system and Acqknowledge v. 3.90 software (BioPac Systems, Inc. 
Goleta, CA). Neuromuscular blockade with I.V. pancuronium (0.1 mg/kg) administered 
acutely post-chamber was necessary in order to accurately measure respiratory gases with 
the mass spectrometer.  
Statistical Methods 
Nitrogen washout curves for the 5 minute period beginning at time=0. Breath-by-
breath measures of end-tidal nitrogen were plotted against time and analyzed using non-
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linear regression to fit a single exponential decay curve to the data using the following 
equation:  
( )Kxy α β−= +  
Where α = peak 
 K = decay constant 
β = plateau 
This curve-fitting generates 3 variables which can be examined: First, a value for 
the y-intercept, hereafter referred to as the ‘peak’. Second, a value for the exponential 
decay constant, which represents the rapidity with which nitrogen is eliminated. Higher 
numbers indicate more rapid elimination. Third, a value for the level which the right-most 
portion of the curve asymptotically approaches, hereafter referred to as the ‘plateau’. This 
number represents the extent to which nitrogen is eliminated with lower numbers 
indicating greater elimination. Since this study was examining only nitrogen washout and 
not initial body nitrogen loading, the peak was not analyzed. One-way ANOVA followed 
by Dunnett’s test using the 100% oxygen-breathing group as the control group was 
employed in order to examine differences between groups in the decay constant and 
plateau. Student’s t-test was used in cases where only 2 groups were being compared. Data 
are presented as Means ± Standard Error. Curve-fitting and statistical analyses were 
performed using GraphPad Prism 4 curve-fitting and statistical software (GraphPad 
Software, Inc. San Diego, CA). 
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Results 
Before plotting nitrogen washout curves as described above all 8 groups were 
separated into 2 broad categories – those with nitrogen in their inhaled gas (Saline + Room 
Air (n=4) and PFC + Room Air (n=4) groups) and those without nitrogen in their inhaled 
gas (Saline + 100% O2 (n=4), Saline + 50/50 HeO2 (n=4), Saline + 80/20 HeO2 (n=4), PFC 
+ 100% O2 (n=4), PFC + 50/50 HeO2 (n=3), and PFC + 80/20 HeO2 (n=4)). The 2 groups 
with nitrogen in their inhaled gas were analyzed separately from the other 6 groups 
because it is not possible for them to eliminate nitrogen to the extent the other groups can, 
given that their inhaled gas contains 80% nitrogen.  
Fitting of the end-tidal nitrogen data from the groups with nitrogen in their inhaled 
gas (Saline + Room Air and PFC + Room Air) to the above single exponential decay 
equation resulted in the curves seen in Figure 11. Details of the nonlinear fit are shown in 
Table 7.  
 
Table 7: Best-fit values resulting from the fit of a single exponential curve to the 
end-tidal nitrogen data obtained from the Saline + Room Air and the PFC + Room Air 
groups.  
 
 Saline + Room Air PFC + Room Air 
Best-fit Values   
Decay Constant 0.02453 0.02871 
Plateau 566.3 563.0 
Standard Error   
Decay Constant 0.02017 0.008135 
Plateau 1.136 0.6879 
95% Confidence Interval   
Decay Constant  -0.01501 to 0.06408 0.01277 to 0.04466 
Plateau 564.1 to 568.5 561.7 to 564.4 
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When the decay constants obtained from the Saline + Room Air and PFC + Room 
Air curve fittings were compared using Student’s t-test it was found that there was no 
statistically significant difference (0.02453 ± 0.02017 vs. 0.02871 ± 0.008135 Saline  vs. 
PFC, t=0.1922, p=0.8539). See figure 12. 
When the plateaus obtained from the Saline + Room Air and PFC + Room Air 
curve fittings were compared using Student’s t-test it was found that the plateau for the 
Saline + Room Air group was significantly higher than that for the PFC + Room Air group 
(566.3 ± 1.136 vs. 563.0 ± 0.6879 mmHg, t=2.485, p=0.0475). See figure 13. 
Fitting of the end-tidal nitrogen data from the groups without nitrogen in their 
inhaled gas (Saline + 100% O2, Saline + 50/50 HeO2, Saline + 80/20 HeO2, PFC + 100% 
O2, PFC + 50/50 HeO2, and PFC + 80/20 HeO2) to the above single exponential decay 
equation resulted in the curves seen in figure 14. Details of the nonlinear fit are shown in 
Table 8.  
One-way ANOVA was used to compare the decay constants obtained from the 
Saline + 100% O2, Saline + 50/50 HeO2, Saline + 80/20 HeO2, PFC + 100% O2, PFC + 
50/50 HeO2, and PFC + 80/20 HeO2 groups. The ANOVA was found to be significant 
(p<0.0001). Dunnett’s post-hoc test using the Saline + 100% O2 group as the control group 
revealed that there were no statistically significant differences between the Saline + 100% 
O2,group and the Saline + 80/20 HeO2, PFC + 100% O2, and PFC + 50/50 HeO2 groups 
(0.03363 ± 0.001518 vs. 0.03067 ± 0.002362, 0.02758 ± 0.001444, and 0.02976 ± 
0.002260, respectively). Dunnett’s post-hoc test also found that the decay constants for the 
Saline + 50/50 HeO2 and the PFC + 80/20 HeO2 groups were significantly higher than that 
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of the Saline + 100% O2 group (0.03363 ± 0.001518 vs. 0.04186 ± 0.001003, p<0.05; and 
0.04481 ± 0.001343, p<0.01, respectively). See figure 15. 
 
Table 8: Best-fit values resulting from the fit of a single exponential curve to the 
end-tidal nitrogen data obtained from the Saline + 100% O2, Saline + 50/50 HeO2, Saline + 
80/20 HeO2, PFC + 100% O2, PFC + 50/50 HeO2, and PFC + 80/20 HeO2 groups.  
 
 Saline + 
100% O2
Saline + 
50/50 
HeO2
Saline + 
80/20 
HeO2
PFC + 
100% O2
PFC + 
50/50 
HeO2
PFC + 
80/20 
HeO2
Best-fit 
Values 
      
Decay 
Constant 
0.03363 0.04186 0.03067 0.02758 0.02976 0.04481 
Plateau 26.17 23.40 21.22 16.82 15.88 17.00 
Standard 
Error 
      
Decay 
Constant 
0.001518 0.001003 0.002362 0.001444 0.002260 0.001343 
Plateau 2.425 1.189 2.903 2.621 2.996 1.177 
95% 
Confidence 
Interval 
      
Decay 
Constant  
0.03066 
to 
0.03661 
0.03989  
to  
0.04382 
0.02604  
to  
0.03530 
0.02475 
to 
0.03041 
0.02533 
to 
0.03419 
0.04218 
to 
0.04744 
Plateau 21.41  
to  
30.92 
21.07  
to  
25.73 
15.53  
to  
26.91 
11.68  
to  
21.95 
10.01  
to  
21.76 
14.69  
to  
19.30 
 
When the plateaus obtained from the Saline + 100% O2, Saline + 50/50 HeO2, 
Saline + 80/20 HeO2, PFC + 100% O2, PFC + 50/50 HeO2, and PFC + 80/20 HeO2 curve 
fittings were compared to the Saline + 100% O2 group using one-way ANOVA it was 
found that the whole model was significant (p=0.0294). Dunnett’s post-hoc test revealed 
that there was no statistically significant difference between the Saline + 100% O2 group 
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and the Saline + 50/50 HeO2 and Saline + 80/20 HeO2 groups (26.17 ± 2.425 vs. 23.40 ± 
1.189 and 21.22 ± 2.903, respectively). Dunnett’s post-hoc test also revealed that the 
plateaus for the PFC + 100% O2, PFC + 50/50 HeO2, and PFC + 80/20 HeO2 groups were 
significantly lower than that of the Saline + 100% O2 group (26.17 ± 2.425 vs. 16.82 ± 
2.621, p<0.05; 15.88 ± 2.996, p<0.05; and 17.00 ± 1.177, p<0.05, respectively). See figure 
16. 
In order to better examine the specific effects of the PFC and the various breathing 
gas mixes independently, the data were pooled based on PFC (n=11) vs. saline (n=12) 
administration as well as by breathing gas administered (100% O2 (n=8), 50/50 HeO2 
(n=7), or 80/20 HeO2 (n=8)).  
Fitting of the end-tidal nitrogen data from the pooled saline- and PFC-treated 
groups to the above single exponential decay equation resulted in the curves seen in figure 
17. Details of the nonlinear fit are shown in Table 9.  
 
Table 9: Best-fit values resulting from the fit of a single exponential curve to the 
end-tidal nitrogen data obtained from the saline- and the PFC-treated groups.  
 
 Saline PFC 
Best-fit Values   
Decay Constant 0.03176 0.03096 
Plateau 22.22 15.98 
Standard Error   
Decay Constant 0.001044 0.0009402 
Plateau 1.566 1.380 
95% Confidence Interval   
Decay Constant  0.02971 to 0.03380 0.02912 to 0.03280 
Plateau 19.15 to 25.29 13.28 to 18.69 
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When the decay constants obtained from the saline- and PFC -treated curve fittings 
were compared using Student’s t-test it was found that there was no statistically significant 
difference (0.03176 ± 0.001044 vs. 0.03096 ± 0.0009402 saline  vs. PFC, t=0.5656, 
p=0.5777). See figure 18. 
When the plateaus obtained from the saline- and PFC-treated curve fittings were 
compared using Student’s t-test it was found that the plateau for the saline-treated group 
was significantly higher than that for the PFC-treated group (22.22 ± 1.566 vs. 15.98 ± 
1.380 mmHg, t=2.967, p= 0.0074). See figure 19. 
Fitting of the end-tidal nitrogen data from the pooled breathing gas groups to the 
above single exponential decay equation resulted in the curves seen in figure 20. Details of 
the nonlinear fit are shown in Table 10.  
 
Table 10: Best-fit values resulting from the fit of a single exponential curve to the 
end-tidal nitrogen data obtained from the 100% O2-, 50/50 HeO2-, and 80/20 HeO2-
breathing groups.  
 
 100 % O2 50/50 HeO2 80/20 HeO2
Best-fit Values    
Decay Constant 0.02649 0.02826 0.03786 
Plateau 19.14 16.29 19.80 
Standard Error    
Decay Constant 0.001056 0.001326 0.001518 
Plateau 2.154 2.175 1.548 
95% Confidence 
Interval 
   
Decay Constant  0.02442 to 0.02856 0.02566 to 0.03086 0.03488 to 0.04084 
Plateau 14.91 to 23.36 12.03 to 20.55 16.76 to 22.83 
 
When the decay constants obtained from the 50/50 HeO2 and 80/20 HeO2 curve 
fittings were compared to the 100% O2 group using one-way ANOVA followed by 
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Dunnett’s post-hoc test it was found that the ANOVA was significant (p<0.0001). 
Dunnett’s post-hoc test showed that there was no statistically significant difference 
between the 100% O2 group and the 50/50 HeO2 group (0.02649 ± 0.001056 vs. 0.02826 ± 
0.001326, p>0.05). It was also found that the decay constant for the 80/20 HeO2 group was 
significantly higher than that of the 100% O2 group (0.03786 ± 0.001518 vs. 0.03363 ± 
0.001518, p<0.01). See figure 21. 
When the plateaus obtained from the 50/50 HeO2 and 80/20 HeO2 curve fittings 
were compared to the 100% O2 group using one-way ANOVA it was found that the 
ANOVA was not statistically significant (p=0.4381). See figure 22. 
Discussion and Conclusions 
As is intuitively obvious, the data gathered from the air-breathing animals 
demonstrates clearly that a low fraction of inspired nitrogen (FIN2) is required for effective 
nitrogen washout to take place. This should come as no surprise. Nitrogen washout, like 
any other process of diffusion, relies on a concentration gradient. So long as there is a high 
level of nitrogen in the alveolar gas there is little driving force to remove nitrogen from the 
blood. At the same time, the degree to which nitrogen can be removed is severely limited. 
Diffusion of nitrogen out of the blood into the alveolar gas will only proceed until the 
concentration of nitrogen is balanced across the alveolar wall. Because of this limit 
imposed on off-gassing, it makes no sense to compare the groups breathing room air with 
the other groups breathing 100% oxygen or heliox mixtures, the latter of which all have 
FIO2 of zero.  
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There were two major findings that came out of this project. Firstly, the 
administration of HeO2 results in higher decay constant values without affecting plateau 
values. Secondly, the administration of PFC results in lower plateau values without 
affecting decay constant values. The decay constant is a measure of how quickly the end-
tidal nitrogen is changing, or practically speaking, how quickly the nitrogen is being 
removed. Higher values indicate that the end-tidal nitrogen is decreasing faster, i.e. 
nitrogen washout is proceeding more quickly.  
When the 6 treatment groups are analyzed separately it is interesting to see that the 
effects of helium were not dose dependant and would appear to be dependant on the 
intravenous therapy administered. When I.V. saline was administered, 50/50 HeO2 resulted 
in a significant increase in the decay constant, while 80/20 HeO2 showed no difference vs. 
100% O2. When I.V. PFC was administered the opposite was true - 80/20 HeO2 resulted in 
a significant increase in the decay constant, while 50/50 HeO2 showed no difference vs. 
100% O2. What this represents is unclear. It may represent a difference in the number and 
size of bubbles lodged in the pulmonary microcirculation which is unrelated to either PFC 
administration or breathing gas, but rather represents a manifestation of the stochastic 
nature of DCS and the relatively small group sizes. In this case examining the data pooled 
based on breathing gas is likely to be much more informative.  
This pooled data indicated that the decay constant in the 80/20 HeO2 group was 
significantly higher than the 100% O2 group, but that the 50/50 HeO2 group was not 
different. This suggests that a high FIHe is required to have maximum impact on increasing 
the speed of nitrogen washout. This is not surprising. Since the benefits of helium lie 
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purely in its physical properties, primarily its density, these benefits will be lost as the FIHe 
decreases. HeO2 has been administered previously for the treatment of experimental 
DCS(3, 78-81). These studies have shown that breathing HeO2 is of benefit both when 
used during recompression and at 1 atmosphere absolute (ATA) after decompression(3, 
78-81). However, there is no record in the scientific literature of previous investigations 
examining the effect of HeO2 on nitrogen washout. Previous studies have examined either 
death rates or used microscopic observation of the growth and shrinkage of bubbles 
deliberately placed in surgically exposed tissue (primarily adipose tissue)(3, 78-81). This 
study, therefore, represents the first examination of the mechanism of the previously-
described benefits of HeO2 breathing after DCS. 
The effect of PFC administration was very different from that of helium. PFC 
resulted in a decrease in the plateau without affecting the decay constant. The plateau 
represents the level to which end-tidal nitrogen is decreased over the period of observation, 
and thus the extent to which nitrogen is removed. Lower values for the plateau indicate that 
more nitrogen has been removed. It was found that the administration of PFC resulted in 
lower plateau values across the board. This was observed amongst all the different 
breathing gases, including the room air groups – all the PFC-treated groups showed 
significantly lower plateau levels than the saline-treated groups. This indicates that PFC 
administration, while not affecting the speed of nitrogen washout, results in nitrogen 
washout proceeding to a greater extent. Only two previous studies have examined the 
effect of PFC administration on nitrogen washout and the findings of this study agree well 
with both of them(99, 196). Both of these previous studies were conducted at 1 ATA, 
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Lundgren et al. using a model where nothing was done to increase the amount of nitrogen 
dissolved in body tissues and Zhu et al. using a venous gas embolism model(99, 196). The 
present study represents the first demonstration that the ability of PFC to enhance nitrogen 
washout is retained in the DCS situation where blood flow through the pulmonary 
microcirculation is disrupted by the presence of large numbers of bubbles. 
The findings of the current study offer insight into the mechanism for the 
previously observed protective effects of both HeO2 breathing and I.V. PFC administration 
in treating DCS. This study demonstrates for the first time that the effect of HeO2 is to 
increase the speed of nitrogen washout. This study also demonstrates for the first time that 
the effect of the PFC is to increase the amount of nitrogen washed out. Although we were 
able to demonstrate statistically significant effects of I.V. PFC, these results must be taken 
with a grain of salt since the magnitude of this effect was so small that it is likely it is of 
little or no clinical relevance. Up until this point it has been widely believed that the 
therapeutic benefit derived from the administration of PFC in cases of severe DCS were 
largely a product of their ability to dissolve inert gases such as N2, and aid in the removal 
of excess N2 from the body, thus alleviating the bubble obstructions and restoring normal 
tissue blood flow(23, 31, 98, 100, 102, 151, 175). This work has demonstrated that, 
although PFC administration does, indeed, increase nitrogen washout, that this effect is so 
small, a mere 6.24 mmHg difference, that it is not very likely that this explaines the 
dramatic protective effects previously observed with the administration of I.V. PFC after 
decompression(23, 31, 100, 102, 151, 175). This novel finding combined with the results 
from study 1 described above shed new light on the likely mechanism of the protection 
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afforded by PFC administration after DCS. These findings suggest strongly that improved 
tissue oxygenation is far more important than minimal increases in nitrogen washout. 
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Figure 11: Nitrogen washout curves from the groups with nitrogen in their inspired 
gas. 
 
Best-fit curves resulting from the fit of a single exponential curve to the end-tidal 
nitrogen data obtained from the Saline + Room Air and the PFC + Room Air groups. For 
Saline + Room Air R2=0.02240, for PFC + Room Air R2=0.1210. 
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Figure 12: Comparison of the decay constants from the groups with nitrogen in 
their inspired gas. 
 
The decay constants from the groups with nitrogen in their inhaled gas were 
compared using Student’s t-test. It was found that there was no significant difference 
between the Saline + Room Air group and the PFC + Room Air groups. 
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Figure 13: Comparison of the plateaus from the groups with nitrogen in their 
inspired gas.  
 
The plateaus from the groups with nitrogen in their inhaled gas were compared 
using Student’s t-test. It was found that the plateau for the PFC + Room Air group was 
significantly lower than that of the Saline + Room Air group. 
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Figure 14: Nitrogen washout curves from the groups without nitrogen in their 
inspired gas. 
= 
0.8300), PFC + 50/50 
HeO2 (R2= 0.7516), and PFC + 80/20 HeO2 (R2= 0.9387) groups. 
 
Best-fit curves resulting from the fit of a single exponential curve to the end-tidal 
nitrogen data obtained from the Saline + 100% O2 (R2= 0.8691), Saline + 50/50 HeO2 (R2
0.9614), Saline + 80/20 HeO  (R2 2= 0.7483), PFC + 100% O  (R2 2= 
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Figure 15: Comparison of the decay constants from the groups without nitrogen in 
their inspired gas. 
 
The decay constants from the groups without nitrogen in their inhaled gas were 
compared to the decay constant of the Saline + 100% O2 group using one-way ANOVA 
followed by Dunnett’s test. It was found that decay constants for both the Saline + 50/50 
HeO2 and the PFC + 80/20 HeO2 groups were significantly higher than that of the Saline + 
100% O2 group. 
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Figure 16: Comparison of the plateaus from the groups without nitrogen in their 
inspired gas. 
 
The plateaus from the groups without nitrogen in their inhaled gas were compared 
to the plateau of the Saline + 100% O2 group using one-way ANOVA followed by 
Dunnett’s test. It was found that the plateaus for the PFC + 100% O2, PFC + 50/50 HeO2 
and PFC + 80/20 HeO2 groups were all significantly lower than that of the Saline + 100% 
O2 group. 
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Figure 17: Nitrogen washout curves from groups pooled based on PFC 
administration. 
 
Best-fit curves resulting from the fit of a single exponential curve to the end-tidal 
nitrogen data obtained from the pooled saline- and the PFC-treated groups. For saline 
R2=0.8201, for PFC R2= 0.8249. 
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Figure 18: Comparison of the decay constants from the pooled saline- and PFC-
treated groups.  
 
The decay constants from the saline- and PFC-treated groups were compared using 
Student’s t-test. It was found that there was no significant difference between the saline- 
group and the PFC-treated groups. 
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Figure 19: Comparison of the plateaus from the pooled saline- and PFC-treated 
groups 
 
The plateaus from the saline- and PFC-treated groups were compared using 
Student’s t-test. It was found that the plateau for the PFC-treated group was significantly 
lower than that of the saline-treated group. 
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Figure 20: Nitrogen washout curves from groups pooled based on breathing gas 
administration. 
 
Best-fit curves resulting from the fit of a single exponential curve to the end-tidal 
nitrogen data obtained from the pooled 100% O2 (R2= 0.8046), 50/50 HeO2 (R2= 0.7805), 
and 80/20 HeO2 (R2= 0.8198) breathing gas groups. 
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Figure 21: Comparison of the decay constants from the pooled breathing gas 
groups 
 
The decay constants from the 50/50 HeO2 and 80/20 HeO2 breathing groups were 
compared to the decay constant of the 100% O2 group using one-way ANOVA followed 
by Dunnett’s test. It was found that the decay constant for the 80/20 HeO2 group was 
significantly higher than that of the 100% O2 group. 
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Figure 22: Comparison of the plateaus from the pooled breathing gas groups 
 
The plateaus from the 50/50 HeO2 and 80/20 HeO2 breathing groups were 
compared to the decay constant of the 100% O2 group using one-way ANOVA followed 
by Dunnett’s test. It was found that there were no significant differences between the 
groups. 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
GENERAL DISCUSSION AND CONCLUSIONS 
 
The problem of DCS is unlikely to pass quietly into the night. In fact, it is more 
likely that the incidence of DCS will increase in the coming years. Although DCS is better 
understood now than it has ever been, the simple fact that it is largely a stochastic 
phenomenon all but guarantees that it will never go away. The probabilistic nature of DCS 
also means that its incidence is likely to increase as the number of people involved in 
diving increases. Current estimates place the number of recreational dives performed 
worldwide per year above 3 million, and the incidence of DCS somewhere between 0.1 
and 9.8 cases of DCS per 100 divers, or between 1.0 and 28.1 cases of DCS per 10,000 
dives(25, 167). Diving is also a sport which is increasing in popularity. A five-fold 
increase in the number of people participating in recreational diving was observed between 
in the 15 year period between 1985 and 2000(161).  
The incidence of DCS in recreational diving alone would be sufficient to indicate 
that DCS will continue to be a problem for the foreseeable future, but recreational diving is 
not the only source of DCS. DCS is also encountered in the much more controlled realms 
of commercial and military diving. Although numbers are much harder to come by, DCS 
incidence in the commercial diving industry is believed to be between 1 case in 800 to 
4000 dives, depending largely on the decompression tables being used(8). The military has 
fundamentally different objectives with its diving programs compared to either recreational 
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diving or commercial diving. Due to the nature of the work, a certain risk, and thus 
incidence of DCS, is considered ‘acceptable’ within the realm of military diving. 
Decompression table development for the US Navy is currently undertaken with the 
understanding that the acceptable incidence of DCS is 2.2%(163). The actual incidence of 
DCS within the realm of military diving is believe to be between 2 and 5 %, again, 
depending largely on which decompression tables are being used(163). Both commercial 
and military diving activities are unlikely to diminish in the short term, so even in these 
communities DCS is likely to be an ongoing problem for the foreseeable future. DCS also 
continues to be a problem in space exploration. When astronauts are operating outside the 
space vehicle their suits must be pressurized to approximately 0.25 ATA in order to allow 
them to operate the joints(168). Given that the crew spaces of both the space shuttles and 
International Space Station are pressurized to approximately 1.0 ATA with a gas miture 
much like room air, great time and care must be taken to denitrify astronauts prior to 
extravehicular activity in order to reduce the risk of decompression sickenss(68, 168). 
Previous studies exploring the use of PFCs to treat and prevent DCS have 
demonstrated that the I.V. administration of PFC emulsions after decompression decreases 
morbidity and mortality in both a clear and consistent fashion(23, 31, 147-149, 151, 196). 
This prior work has all been done in conscious, spontaneously breathing, freely moving 
animals. This laboratory is the only laboratory conducting DCS research in anaesthetized, 
instrumented animal models. As such we are uniquely equipped to examine not only the 
survival benefits of PFC administration, but to elucidate the mechanism by which these 
benefits are provided. The studies described in this dissertation were the first studies 
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purposed to examine two potential mechanisms by which PFCs exert their protective 
effects – namely that they improve oxygenation and that they improve nitrogen (or any 
other inert gas) washout.  
Study 1 in Chapter 2 above demonstrated that PFC administration improved whole-
body oxygenation. Although it is rather intuitive that the administration of a therapy which 
is known to dissolve greater quantities of oxygen than blood plasma , such as PFC, should 
increase arterial oxygen content, this is the first study to demonstrate that this is, in fact, 
the case in vivo. That PFC is also able to increase both and demonstrates that this 
increased oxygen carrying capacity granted by PFC administration has functional benefits 
as well. Thus it is likely that at least a portion of the benefits previously observed with PFC 
administration are directly attributable to improved tissue oxygenation. Unfortunately this 
study was only able to make these measures at the whole-body level. Moving forward it 
would be important to examine the effects of PFC administration on , and  
in specific tissues, ideally in areas where blood flow is known to be obstructed by bubbles. 
Furthermore, in order to examine the mechanism by which PFC improves tissue 
oxygenation, it would be beneficial if some means to track the location of the PFC 
emulsion particles could be devised. While labeling the PFC itself is difficult due to their 
non-reactivity it might be possible to label the emulsifiers, and thus track the location of 
the emulsion particles. These studies could be used to determine if the PFC particles are 
able to flow past bubble obstructions, or perhaps move through them. Similarly, in order to 
examine how PFC improves oxygen delivery to cells and cellular organelles, labeled PFC 
emulsion particles could be used to determine if the PFC extravasates or remains within 
2VO 2DO
2aC O 2DO 2VO
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the circulatory system. Much work remains to be done in order to fully understand exactly 
how PFC improves oxygenation.  
Study 2 in Chapter 3 above demonstrated that PFC is able to increase the degree to 
which nitrogen is removed, but not the speed with which it is removed. This same study 
also demonstrated that high FIHe was able to increase the speed with which nitrogen was 
removed, but not the degree to which it was removed. If nitrogen washout is to be studied 
in the future it would be desirable to carry such studies over longer periods of time, and to 
use other techniques in addition to real-time respiratory mass spectrometry to examine 
exhaled nitrogen. If exhaled gases were collected in a bag and the contents of the bag 
examined at various time points, data could be gathered with respect to not only the 
instantaneous partial pressure of nitrogen in the gas, but also the volume of gas expired. 
The above conclusions from Study 2 suggest a potential beneficial effect of 
combining both PFC and high FIHe for increasing the amount and rapidity of nitrogen 
washout. This study was, however, neither powered, nor designed to elucidate differences 
seen due to the combined effects of PFC administration and high FIHe. As such this 
investigator does not believe that such effects would be substantive.  
The beneficial effects of helium were only observed when the inspired breathing 
mix was 80% helium. With only 20% of the inspired gas consisting of oxygen it is unlikely 
that the oxygenation benefits of the PFC would be retained. This investigator also 
questions the wisdom of administering breathing mixes containing high FIHe after 
decompression. Although the research done to date suggests that HeO2 breathing with a 
high FIHe after decompression results in faster bubble shrinkage and disappearance, the 
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results of these studies are of questionable relevance to clinical DCS(3, 10, 78-81). First, 
these studies were all conducted in rats, and it is well understood that rats do not develop 
DCS in the same way that humans and larger mammals do(39, 97). Their small body mass 
appears to offer a protective effect and more severe dive profiles are required to reliably 
generate DCS in rats than is required for larger mammals. Additionally these studies were 
not studying DCS per se, but rather were examining the growth, shrinkage, and 
disappearance of bubbles deliberately injected into adipose tissue prior to a hyperbaric 
exposure. The dive profile itself was not severe enough to result in de novo bubble 
formation(3, 10, 78-81). Although very interesting, this is a very different phenomenon 
from clinical DCS. It is unlikely that tissue gas tensions are as high in these models as they 
would be in clinical DCS. As such the growth and shrinkage of bubbles could not be 
expected to follow a similar time course in these models as would be the case in DCS.  
Even if we were to interpret these results as representative of the growth and 
shrinkage of bubbles in circulation, the fastest shrinking bubbles required nearly 70 
minutes to disappear(79-81). Although the removal of bubbles obstructing circulation and 
restoration of normal blood flow are important factors in tissue injury, the reason blood 
flow restoration is important is to restore oxygen delivery. It seems foolish to this 
investigator to hamper the ability of PFC to deliver oxygen to tissue by decreasing the FIO2 
in order to decrease bubble dwell time from several hours to over 1 hour. It would appear 
to be of greater benefit to restore some oxygen delivery to tissue, even if it isn’t a complete 
return to baseline, by administering PFC in combination with 100% oxygen breathing. 
This scenario seems more likely to maximize tissue survival in the case of DCS. 
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In future work studying the use of PFC for treating DCS, great care should be 
exercised in model choice. Previous work examining PFC administration to swine 
demonstrated clearly that pigs develop a pulmonary hypertensive response to PFC which is 
severe enough to result in decreased cardiac output(152). Findings from study 1 above 
demonstrate that a similar, though less severe, response occur in sheep as well. It is likely 
that this response will be observed in all cloven-hoofed animals. In order to get the clearest 
possible picture of how PFC effects oxygenation, it would be desirable to utilize a species 
in which this response does not occur.  
Other issues in model selection include the use of conscious vs. anaesthetized 
animals, as well as spontaneously breathing vs. ventilated animals. These issues become 
important in the development and evolution of DCS. As discussed in the introduction 
above, one likely mechanism for the formation of bubbles during the development of DCS 
is cavitation nucleation. This occurs as a result of motion. Therefore the question of 
whether to use conscious vs. anaesthetized animals arises. Anaesthetized animals do not 
move spontaneously, and any movement imposed externally by investigators will not 
duplicate the normal muscle and joint movement as it would occur in a conscious, free-
moving animals. Similarly, a spontaneously breathing animal is able to regulate its 
ventilatory drive in response to stimuli such as changing arterial pCO2. A ventilator-
dependant animal will not be able to alter its ventilatory pattern in response to such stimuli. 
As with all model choices, no one scenario is universally a better choice. Although a 
conscious, spontaneously breathing, free moving animal might be ideal for examining 
variables such as time to onset of symptoms, or mortality, it is very difficult to use such 
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models for the invasive monitoring of physiological parameters such as cardiac output. 
Models must be selected based on experimental objectives. 
This work has demonstrated for the first time that the mechanism by which PFC 
exerts its protective effects includes both improved oxygenation and increased nitrogen 
removal. It is likely that the observed effects on oxygenation are more important in terms 
of explaining the previously observed beneficial effects of PFC in treating DCS than are 
the effects on nitrogen washout. Arterial oxygen content was increased 11% over saline 
control, while  was increased by 10% and was increased by 22%. These are 
substantial increases in oxygenation. Meanwhile when the nitrogen washout curves were 
examined it was found that the plateau value for the PFC-treated group was 28% lower 
when compared to the saline control group. Although this seems like a large relative 
difference, in absolute terms the difference is only 6.24 mmHg.  
2DO 2VO
Over the course of a long period of time this small difference may account for a 
substantial difference in the total volume of nitrogen washed out. It is also likely that the 
time required for the dissolution of bubbles is not decreased to a level which would 
eliminate the interruption of blood flow and resultant hypoxia induced by bubbles lodging 
in the circulation. The direct effect of PFC administration on the time required for bubble 
dissolution has never been studied, but the effects of other therapies such as HeO2 
breathing have been studied, as mentioned above. These studies indicated that when 
breathing air, the worst possible breathing gas to treat DCS, bubbles persisted longer than 
220 minutes(79-81). The exact time is unknown because bubbles persisted beyond the 
period of observation. While breathing oxygen, the current gold-standard of DCS therapy, 
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bubbles persisted for approximately 150 minutes on average(79-81). Breathing 50/50 
HeO2, the gas which resulted in the shortest time required for bubble dissolution, reduced 
bubble persistence to approximately 100 minutes on average(79-81). Even if we were to 
suppose that the PFC is able to decrease bubble persistence by 100% over 50/50 HeO2, 
bubble persistence times would still average 50 minutes. Obstructing circulation for 50 
minutes is more than long enough to cause permanent injury in sensitive tissues such as 
neural tissue where it is generally accepted that interruption of blood flow for intervals 
greater than 6-10 minutes will result in permanent injury. 
In conclusion, previous work has demonstrated clearly that PFC decreases DCS 
morbidity and mortality. The work described in this dissertation demonstrated that the 
most likely mechanism for the observed benefits is that PFC improves capacity of the 
circulatory system to carry and deliver oxygen to tissue, as well as increasing the ability of 
tissue to take up and use that oxygen. Although PFC does improve nitrogen washout, this 
is likely a minor contributor to its previously-observed efficacy in the treatment of DCS. I 
believe it is likely that PFC administration will one day become an adjunctive therapy in 
the treatment of DCS and perhaps even a definitive therapy in mild-to-moderate cases. 
This will require not only further animal study to demonstrate efficacy in less severe 
models of DCS, but also extensive human testing in order to demonstrate a lack of toxicity, 
appropriate dosing for humans, and will likely also require the development of new 
recompression tables for use in patients who still require recompression after PFC 
administration. 
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Introduction 
Gas anaesthesia is arguable one of the most important medical advances of the 
last 200 years. Introduced to the Americas some 160 years ago, these drugs form the 
foundation that all modern surgery is based on. Without surgical anaesthesia to render 
patients immobile, insensitive to pain, and to abolish, or at least limit their memories of 
the surgical experience, modern surgery would not be possible. Inhaled anaesthetics are 
also among the most dangerous and poorly understood drugs available in the modern 
arsenal – so much so that an entire specialty of medical practice has been developed in 
order to ensure that those using these drugs have the proper training and experience to do 
so safely. While gas anaesthesia has been a great boon for medicine, inert gas narcosis 
has been the scourge of deep sea diving. Inert gas narcosis has placed some fairly strict 
limits on the depths to which deep sea diving can be conducted safely, greatly limiting 
our ability to explore the 70% of our planet covered by water, except through indirect 
means such as the use of submersibles. In fact, it has been remarked that we know more 
about the surface of Mars than we do about the deep ocean. These two topics of 
discussion seem so far removed from one another that they have never really been 
explored in tandem, but what if they are not really separate topics after all? What if gas 
anaesthesia and inert gas narcosis are, in reality, different manifestations of the same 
phenomenon? 
History 
The phenomenon now known as nitrogen narcosis, or more broadly as inert gas 
narcosis, is a prime example of pharmacological activity of a so-called inert gas. From as 
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early as 1835 (19, 65, 75), it was understood that hyperbaric exposure resulted in 
symptoms such as sleepiness, impaired judgement, and hallucinations resembling 
intoxication or drunkenness (19, 55, 75). Over the years a succession of explanations for 
these observations has been postulated, including direct effects of pressure (19, 55, 75), 
high partial pressures of oxygen (19, 35, 75), underlying psychological factors such as 
latent claustrophobia (19, 63, 75), impurities in the breathing gas (19, 63, 75), and carbon 
dioxide. None of these proposed mechanisms were ultimately able to explain the 
mechanism of the observed symptoms without breaking down at some point. After a 
century of investigation into the mechanism of what came to be know as ‘compressed air 
narcosis’, in 1935 Behnke et al. first proposed what is now the commonly held theory 
that the raised partial pressure of nitrogen was responsible for the observed symptoms 
(13, 19). For several years there was a major rift in the emerging hyperbaric community 
between the proponents of the nitrogen hypothesis and the carbon dioxide hypothesis (11, 
12, 19, 75). However, work in the early 1970’s by Hesser et al. reconciled the nitrogen 
and CO2 theories by demonstrating that the effects of nitrogen were the primary cause of 
narcosis, but CO2 also had an additive effect on narcosis (19, 61, 62, 75). 
Modern hypotheses 
Inert Gas Theory 
When Behnke et al. first proposed the currently held theory that the nitrogen (or 
more broadly, the inert gas) fraction of the breathing gas is primarily responsible for 
narcosis (13) in 1935, their assertion was based on what has come to be known as the 
Meyer-Overton hypothesis, which, in brief, states that the narcotic potency of an 
anaesthetic (or an inert gas) is related to its lipid solubility (78, 88). Lipid solubility is the 
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one physical property of inert gases that has been found to correlate consistently with 
their narcotic potency (19, 75). The Meyer-Overton hypothesis, with regards to inert gas 
narcosis, was found to be tenable by Carpenter. He showed that at their isonarcotic partial 
pressures, that is, the partial pressure at which each gas shows comparable pharmacologic 
effects, the inert gas concentration dissolved in the lipid phase is very similar across 
many gasses, but the partial pressure of gas required varies from 0.045 to 165 ATA (19, 
29). Figure 1 also illustrates that lipid solubility correlates with relative narcotic potency 
better than other physical properties (75). 
This assumes that the mechanism of action for the narcotic effect of inert gases is 
some sort of interaction with the lipid component of the central nervous system, which is 
currently one of the plausible sites of action for anaesthetics. This has not always been 
the case. The aqueous phase has also been suggested as a possible alternative (82, 89). 
The first aqueous phase hypothesis is based on the formation of hydrates (19). Pauling 
theorized that clathrates were formed in the aqueous phase such that the inert gas atoms, 
which he called ‘guests’, are held by Van der Waals forces in crystalline cages formed by 
the ‘hosts’, or molecules from within the cell, namely water molecules (89). 
Unfortunately these hydrates would be unstable under body conditions, so Pauling was 
forced to assume that there was some stabilizing factor present, such as the charged side-
chains of proteins to make his theory workable (19, 89). Under this hypothesis the 
clathrates caused narcosis by increasing the impedance of nerve tissue, trapping ions 
involved in nerve conduction, and decreasing metabolism (19, 89). Miller proposed 
another aqueous-phase model which, although related, did not rely on hydrates (19, 82). 
Instead, Miller suggested that the presence of gaseous anaesthetics, such as inert gases, 
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resulted in an increase in the size of highly ordered shells of water molecules surrounding 
the dissolved gas molecule (19, 82).  These ‘icebergs’ would decrease conductance in 
brain tissue, stiffen lipid membranes, and occlude ion channels (19, 82). In the mid-to-
late 1960’s work was done to settle the lipid phase vs. aqueous phase debate. This work 
demonstrated clearly that lipid solubility was a far better indicator of narcotic potency 
than hydrate dissociation pressure (43, 79, 80). No evidence was found in these studies to 
support the idea that the aqueous phase was the critical phase for the action of anaesthetic 
gasses. 
Mechanisms 
Once it was established that the site of action was, indeed, within the lipid phase 
rather than the aqueous phase, hypotheses began to emerge regarding what was actually 
taking place within the lipid phase that would result in narcosis with identical signs and 
symptoms being induced by a broad collection of gasses with no common structural 
features (75). Many hypotheses have evolved to explain the mechanism of inert gas 
narcosis and anesthesia, including hypoxia, depression of metabolism, cell membrane 
stabilization and stiffening causing decreased ion permeability, inhibition of the sodium 
extrusion pump, increased production of inhibitory neurotransmitters such as gamma 
aminobutyric acid (GABA) and interference with adenosine triphosphate (ATP) 
production (15, 25, 44, 70, 84, 91, 93). These fall into two broad categories, biochemical 
hypotheses or biophysical hypotheses. Biochemical theories imply some effect on 
respiratory enzyme systems, while biophysical theories imply some interaction with, or 
within part of the cell, such as the cell membrane (45, 59, 84, 101, 115). Until recently, 
no good evidence had been found to support biochemical changes at pressures relevant to 
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the clinical manifestations of inert gas narcosis (27, 28, 71, 74, 103, 111). This suggested 
that the narcotic action is more likely biophysical than biochemical and evolved into the 
‘unitary hypothesis of narcosis’ – that the mechanism of narcosis is the same for all 
anaesthetic gasses (75). 
 By the late 1950’s, the site of action of narcotic gasses had been attributed to 
synapses in the central nervous system. This was deduced largely from the work of 
Carpenter in the mid 1950’s. He demonstrated that extremely high pressures (310-340 
ATA) of argon, a gas with a narcotic potency more than twice that of nitrogen, were 
required to effect a block of conduction in isolated peripheral nerve preparations. Yet 
argon at a mere 18 ATA of pressure was sufficient to abolish any response to electrical 
stimulus applied to the foot pad of mice (29, 30). This suggests strongly that higher level 
functions in the brain are much more susceptible to inert gas narcosis than peripheral 
nerves. Later work examining reflex inhibition in the spinal cord demonstrated that 
inhibitory synaptic mechanisms were affected by inert gas narcosis before excitatory 
mechanisms (14, 15, 31), and that inert gas narcosis, like general anaesthetics, affects 
cells in the anterior horn of the spinal cord (7, 108, 109). 
Lipid/Membrane Hypotheses 
 Physical hypotheses, based on the polarizability and the volume of inert gas 
molecules are generally much simpler and, according to some, seem more likely than 
biochemical hypotheses (19, 84). The critical volume hypothesis of general anaesthesia 
proposed that narcosis occurred when the anaesthetic agent entered the lipid part of the 
cell in sufficient quantity to cause the lipid portion of the cell, in particular the plasma 
membrane, to swell (72, 81). Accordingly, changes in lipid volume ought to differentiate 
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the anaesthetized from the unanaesthetized state. The critical volume hypothesis is 
supported by observations that anaesthetics and inert gases at increased ambient pressures 
expand the volume of lipid monolayers and bilayers, bulk phase solvents, oils, and even 
rubber (105). This hypothesis is further supported by the observation that gas anaesthesia 
can be reversed with the application of hydrostatic pressure, see figure 2 (72, 81, 99). The 
quantitative aspect of this hypothesis was developed which suggested that a 0.4% 
expansion of the membrane would be required to produce anaesthesia (73). 
Although elegant in its simplicity, there are critical elements of this hypothesis 
that do not agree with observations. The critical volume hypothesis predicts that the 
percentage change in anaesthetic potency ought to be linearly related to pressure, and that 
the slope of this relationship ought to be the same for all anaesthetic agents (59). This has 
not been found to be true. It has been demonstrated that there is not a universal linear 
relationship between pressure and the anaesthetic dose required to maintain the same 
level of anaesthesia (59, 67, 107, 116). Quite the opposite, it has been shown that these 
pressure-anaesthetic interactions are curvilinear, and differ depending on the anaesthetic 
in question (59, 67, 107, 116). For instance, the amount of nitrogen required to maintain a 
given level of anaesthesia increases with pressure to ~50 ATA, at which point it plateaus 
and there is no further increase for pressures up to ~130 ATA (59, 67, 107, 116). 
Requirements for isoflurane, on the other hand, decrease up to pressures of ~8 ATA, after 
which they increase sharply, and continue to increase up to pressures of ~100 ATA (59, 
67, 107, 116). Additionally, it has been observed that there is no appreciable increase in 
membrane thickness at narcotic concentrations of various agents (52, 106). 
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These observations led to the postulation of the multi-site expansion hypothesis 
(59). There are 5 key elements of this hypothesis (19, 59):  
• General anaesthesia or narcosis can be produced by the expansion of more 
than one molecular site and these sites may have different physical 
properties. 
• The physical properties of a molecular site may themselves be influenced 
by the presence of anaesthetics or pressure (i.e. compressibility) 
• The molecular sites do not behave as if they were bulk solvents but have a 
finite size and a finite degree of occupancy 
• Pressure need not necessarily act at the same site as the anaesthetic in 
order to reverse anaesthesia. Depending on the anaesthetic, one of the sites 
may predominate in determining the interaction between anaesthesia and 
pressure 
• The molecular sites for anaesthesia are not perturbed by a decrease in 
temperature in a manner analogous to an increase in pressure 
Although appreciable increases in membrane thickness have not been observed at 
clinically relevant doses of anaesthetic gases, it has been demonstrated that membranes 
do expand laterally in the presence of anaesthetic gases (32). This study found that 
narcotic agents such as nitrous oxide have an affinity for lipid monolayers, and that inert 
gases at partial pressures sufficient to bring about the observed clinical effects of inert gas 
narcosis should act at lipoprotein-water interfaces to cause a decrease in surface tension 
of 0.39 dynes/cm (19, 32). Work by Bennett et al. was able to confirm that inert gases do 
indeed penetrate lipid monolayers and affect surface tension as Clements and Wilson 
127 
suggested (18). Exactly how these changes could affect anaesthesia is not well 
understood, but it is believed that these changes in surface tension alter the function of 
the ion receptors and channels involved in synaptic transmission (18, 19, 32). 
Other work on membrane model systems suggested that anaesthetic gases may 
also alter ion permeabilities. While examining cation permeability in membrane model 
systems, Bangham et al. found that n-alkyl alcohols, chloroform and ether result in a 
transient, reversible increase in membrane cation permeability (10). Inert gases behave 
the same way. Bennett and Hayward were able to demonstrate this by examining in vivo 
cerebrospinal fluid (CSF) levels of sodium, potassium and chloride while measuring 
auditory evoked potentials in cats. They found a significant decrease in CSF sodium and 
chloride, as well as the amplitude of cortical auditory evoked potentials, in animals 
compressed to 11 ATA breathing a mix of 80% nitrogen/20% oxygen or 80% argon/20% 
oxygen when compared to breathing 80% helium/20 % oxygen at 11 ATA or room air at 
ambient pressure (17). This is further supported by studies by Johnson and Miller as well 
as by Galey and van Nice (53, 64). Johnson and Miller found that when liposomes were 
exposed to butanol, ether and nitrogen in doses which would be just sufficient to abolish 
the righting reflex in newts, an increase in the permeability for potassium and rubidium 
was observed.  An application of 152 ATA of pressure was required to counterbalance 
the permeability changes (64). Galey and van Nice found that pressures of nitrogen up to 
88 ATA stimulate active sodium efflux and potassium influx across the red blood cell 
membrane, and that the effect is abolished by ouabain (53). They also showed that 
hyperbaric pressures of the non-narcotic gas helium, rather than nitrogen, tended to 
inhibit active sodium and potassium transport (53). Other work by this group using rat 
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brain synaptosomes showed that hyperbaric pressures of argon would stimulate 
potassium uptake by the synaptosomes while 69 ATA of helium or hydrostatic pressure 
inhibited the accumulation of potassium (19). This suggests that anaesthesia and narcosis 
may be the downstream product of gases dissolving into the membrane at various sites, 
altering ion conduction, and thus synaptic conduction, and ultimately consciousness. 
More recently, Abraini modified this multi-site expansion model based on results 
obtained from human trials using hydrogen as a compression gas. He proposed a 
theoretical reconsideration of the interaction between inert gases at hyperbaric pressure, 
and the effects of pressure itself. According to this hypothesis, narcotic gas and pressure 
act at different hydrophobic sites and narcosis occurs when a critical level of expansion is 
reached at some cellular hydrophobic site in the central nervous system (1, 19). As far as 
light inert gases are concerned, all narcotic gases act at a common hydrophobic region 
through a non-specific mechanism (1, 19). This hypothesis suggests that the psychotic-
like symptoms observed in humans at high pressure may be a paroxysmal symptom of 
narcosis, not simply a manifestation of the high pressure nervous syndrome (HPNS), and 
is a result of the sum of the individual narcotic potencies of the various inert gases in the 
breathing mix (1). This hypothesis was tested mathematically against various lipid 
solubility theories of inert gas narcosis and was found to be sound (1). This suggests that, 
depending on the environmental parameters (breathing mix, pressure), symptoms of inert 
gas narcosis or HPNS appear when a critical imbalance is reached between the narcotic 
actions of inert gas and the actions of pressure, which tend to reverse narcosis, on their 
respective hydrophobic sites (1, 19). Accordingly, inert gas narcosis and HPNS can 
antagonize each other or can occur simultaneously (1, 19). 
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Given the understanding that inert gas narcosis was somehow connected to 
changes in synaptic conduction in the CNS, some researchers began to investigate 
changes in neurotransmitters with hyperbaric exposure. Changes in levels of dopamine 
and norepinephrine have been observed by several groups, but whether an increase or 
decrease is observed seems to depend on what area of the brain is under investigation 
rather than the pressure applied (9, 77, 100). For instance, in the hypothalamus, dopamine 
and norepinephrine were shown to be decreased in response to 100 ATA trimix 
(helium/nitrogen/oxygen) and to 20 ATA nitrogen/oxygen mixtures, but were increased 
in the caudate nucleus (19, 77). Unfortunately these changes may not have anything to do 
with inert gas narcosis. Rostain and Forni were able to demonstrate a similar increase in 
striatal dopamine release in response to 90 ATA helium/oxygen mixture, 90 ATA 
helium/nitrogen/oxygen mixture (5% nitrogen), and 90 ATA helium/hydrogen/oxygen 
mixture (66% hydrogen) (19, 100). These mixes should have quite different narcotic 
potencies, but appeared to cause the same change in dopamine levels. These changes 
were attributed to, and are likely due to pressure alone, not narcosis (100). Balon et al., 
while also looking at striatal dopamine release, found a 20% decrease in dopamine 
release in rats exposed to 30 ATA breathing a nitrogen/oxygen mix (9). This suggests 
that neurotransmitter release in response to hyperbaric exposure and inert gases is quite 
complex. It would appear that exposure to low pressures breathing a mixture of 
nitrogen/oxygen decreases striatal dopamine release, while exposure to high pressures 
breathing a helium/oxygen mixture increases dopamine release. Unfortunately it is very 
difficult to separate out the effects of the inert gas from the effects of pressure per se 
because gases with high narcotic potency will result in unconsciousness at high pressures. 
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Thus, in order to expose an in vivo preparation to high pressures, helium must be used as 
a diluent gas if any sort of behavioural observations are to be made. So long as gas 
pressure is used to generate a hyperbaric exposure it will remain near-impossible to 
distinguish the effects of high-pressure helium from those of pressure per se. Nonetheless 
it would appear that there are consistent, reproducible changes in dopamine release in 
response to hyperbaric exposure. This suggests that neurotransmission is likely altered 
under hyperbaric conditions and may offer a partial explanation of inert gas narcosis.  
Other work has suggested that nitric oxide may play a role in narcosis. Vjotosh et 
al. found that when rats were compressed to 41 ATA breathing air, they showed 
alterations in motor activity at 5-12 ATA, ataxia at 10-34 ATA, and side body position at 
26-41 ATA. These were taken as signs of nitrogen narcosis. When treated with the nitric 
oxide synthase inhibitors L-NAME or 7-NI, the above mentioned signs were abolished or 
attenuated (19, 114). While interesting, these results must be taken with a grain of salt. 
Air breathing at pressures greater than 10 ATA makes acute oxygen toxicity a serious 
risk. Since seizures are one of the symptoms of acute oxygen toxicity, the indicators that 
this group used as signs of narcosis may make narcosis and oxygen toxicity difficult to 
distinguish. 
Protein/Metabolic Hypotheses 
Research attention is now focussing on the possibility of direct interactions 
between inert and anaesthetic gases and proteins, lipoproteins, and other hydrophobic 
sites within the cell (2, 48-51). Much of this evidence comes from the anaesthesia 
community and the study of volatile, inhaled anaesthetics in general. If inert gas narcosis 
was solely a matter of gas dissolving in lipid membranes it would be expected that the 
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onset of narcotic effects would be linearly related to the rate of increase in pressure (19). 
The finding that this relationship was, in fact, sigmoidal suggests that the inert gas 
molecules are interacting with protein receptors directly and act as allosteric modulators 
of their activity (2, 19). The idea that the mechanism underlying anaesthesia involves an 
interaction with proteins is not new. This was first proposed by Claude Bernard in 1875 
(20). He came to this conclusion based on the way some anaesthetic potencies deviated 
from that which would be predicted from their lipid solubility alone, combined with the 
understanding that many proteins contain small hydrophobic domains which would allow 
for interactions with small, hydrophobic compounds (20, 41). Unfortunately the 
interactions between proteins and narcotic compounds appear to be very short-lived, on 
the order of a millisecond or less (41). Conventional binding assays are simply unable to 
measure such low affinity binding (41).  
Since direct measurements of binding are not possible, those interested in 
studying protein-based mechanisms of anaesthesia and narcosis have resorted to 
molecular pharmacology and assays of protein activity in various in vitro preparations 
(41). These techniques have evaluated possible protein/anaesthetic interactions based on 
two criteria: ‘plausibility’ and ‘sensitivity’. Plausibility refers to the degree to which 
changes in protein activity observed in the preparation lines up with our preconceptions 
of anaesthetic mechanisms (41). For instance, it is believed that anaesthesia and narcosis 
are products of CNS depression; therefore the observation that an anaesthetic inhibits 
proteins involved in excitatory synaptic transmission, or activates proteins involved in 
inhibitory synaptic transmission would fit the ‘plausibility’ criterion. The sensitivity 
criterion would come in to play in order to evaluate the dose-dependence of the observed 
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changes in protein activity. This criterion would be satisfied if the observed in vitro EC50 
is similar to the observed clinical EC50. Plausibility, in this sense, is certainly a very 
fuzzy concept. Our understanding of the neurophysiology of consciousness is very 
limited. Consequently our understanding of altered states of consciousness is even more 
limited, so plausibility is very much open to the subjective interpretation of the 
investigator. 
Inhalational anaesthetics including inert gases have been investigated in several 
different in vitro systems and have been found to alter the functions of many enzymes, 
receptors, transporters, ligand- and voltage-gated ion channels, as well as structural 
proteins (42). A growing body of evidence suggests that inhalational general anaesthetics 
work through interactions with proteins, particularly post-synaptic ligand-gated ion 
channels (6, 34, 37, 49, 51, 119). These interactions fit well, not only with the plausibility 
criterion, but with the sensitivity criterion; the doses observed to have appropriate in vitro 
effects are very similar to clinical doses used to produce general anaesthesia (60). The 
idea that inhaled anaesthetics exert their effects through modulation of inhibitory post-
synaptic ligand-gated ion channels is interesting. When activated by the binding of the 
appropriate ligand (ex. GABA) these chloride channels open and chloride flows into the 
cell causing a hyperpolarization and decreasing the likelihood of action potential 
propagation (41). Clinically effective concentrations of several inhaled anaesthetics have 
been demonstrated to potentiate both GABA- and glycine-modulated chloride currents in 
vitro (85, 86).  
Several problems still exist with the hypothesis that inhaled anaesthetics operate 
through the modulation of ligand-gated ion channels such as the GABA receptor. First, in 
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vitro, it has been shown that at high doses of anaesthetic drugs (above 1 mM), GABAA 
activity tends to be inhibited, yet clinically, increasing anaesthetic doses lead to deeper 
anaesthesia, not reversal (85, 86). Second, in neonatal rodents, chloride gradients are 
reversed, thus GABA acts as an excitatory neurotransmitter, but inhaled anaesthetics are 
still effective in these animals, although slightly higher doses are required (87). Third, if 
the anxiolytic effect of benzodiazepines is a result of potentiation of the GABAA 
receptor, inhaled anaesthetics must act through a different mechanism since their effect is 
decidedly non-anxiolytic (41). The early stages of general anaesthesia induced with 
inhaled anaesthetics produces an excitatory phase, which can produce seizure-like 
activity, whereas benzodiazepines prevent seizures (41). Fourth, chloride channel 
blockers and GABAA antagonists have only minimal effects on the potency of inhaled 
anaesthetics (57, 98). This evidence suggests that, although volatile anaesthetics can 
modulate ligand-gated chloride channel activity at clinically relevant concentrations in 
vitro (and possible in vivo), it is unclear how this effect is related to anaesthesia. 
Anaesthesia may be a product, not of interaction with a single protein, but of 
interaction with multiple molecular targets. This is suggested by the observations that 
inhaled anaesthetic agents affect multiple proteins, as well as the fact that multiple 
anaesthetics with diverse molecular structures all produce the same end result: 
anaesthesia (41). There is evidence for unique binding sites for several inhaled 
anaesthetics on a single target, but it seems unlikely that a single molecular target would 
have specific binding sites for diverse molecular structures ranging from xenon to nitrous 
oxide to sevoflurine (40, 56). Other evidence suggests that there may be a single, 
selective target for each anaesthetic, but it seems unlikely that all these molecular targets 
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would lead to the same end result – anaesthesia (36, 95). This finding does, however, 
provide reasonable grounds to believe that interactions with multiple molecular targets 
may converge to produce the single effect of anaesthesia (41).  
It should be remembered that specific interaction with a protein target and 
multiple sites of action are not mutually exclusive. It is well understood that ATP, 
oxygen, and calcium all bind selectively with multiple different targets. Volatile 
anaesthetics have also been shown to bind selectively with multiple different targets, 
including firefly luciferase, serum albumin, myoglobin, adenylate kinase, haloalkane 
dehalogenase and T4 lysozyme (21, 47, 94, 102, 104, 113). Even more compelling 
evidence comes from autoradiograms of rat brain slices probed with a radiolabelled 
halothane derivative. The radiographs revealed widespread binding throughout the brain 
whose distribution did not match that of any known receptor or channel (39), see Figure 
3. Furthermore, the binding was reduced to background levels in the presence of a 10-
fold excess of unlabelled halothane (39). When extracted and separated, multiple brain 
proteins were found to be specifically labelled in a saturable and stoichiometric manner 
with estimated affinities near the clinical EC50 (38). 
The nature of the interaction between anaesthetics and proteins may lie in the 
structure of proteins themselves. It is understood that proteins fold into complex 3-
dimensional structures which are not solid, but rather contain cavities. These cavities are 
believed to be critical structural elements in protein function as they introduce areas of 
instability which allow conformational changes to take place (24, 112). These cavities 
within the hydrophobic core of proteins provide plausible binding sites consistent with 
the observation that anaesthetic potency is correlated with lipid solubility. That potent 
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anaesthetics exhibit weak polarity is also consistent with the hypothesis that they bind in 
protein cavities as most cavities are also weakly polar (41). The elements of protein 
secondary structure which form the surface of these cavities could also provide an 
explanation for the weak stereoselectivity observed with some anaesthetics such as 
isoflurane (51, 76). Occupancy of these cavities by anaesthetic molecules could affect 
anaesthesia by limiting the motion that underlies protein activity (41). Studies have 
indicated that occupancy of cavities by small, hydrophobic molecules does reduce protein 
motion (24, 112). This is clearly a multiple target hypothesis, and nicely reconciles 
results form binding and functional studies (41).  
Xenon 
Thus far the terms ‘inert gas narcosis’ and ‘anaesthesia’ have been, to a degree, 
used interchangeably. This is due to both the hypothesis that all anaesthetics act through 
the same basic mechanism, as well as the observation that inert gas narcosis resembles 
early stages of anaesthesia and that inert gases can produce general anaesthesia if 
delivered at sufficient partial pressures. The inert gas xenon exemplifies much of this 
overlap and somewhat loose use of terminology. Xenon is an inert gas whose narcotic 
potency is so high that it can be used as a general anaesthetic at 1 ATA (92). If it can be 
assumed that inert gas narcosis exists as a single condition, regardless of the inert gas in 
question (to a large extent the research community has already done so in order to try to 
separate narcotic effects from pressure effects), what is understood about the mechanism 
of xenon anaesthesia can be extended to all inert gas narcosis and gas anesthesia (2, 9, 16, 
53, 92, 99).  
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Investigations into the mechanism of action of xenon gas anaesthesia present a 
microcosm of investigations into the mechanism of action of the entire scope of 
inhalational anaesthesia. Both lipid (membrane) and direct interaction with protein 
hypotheses abound. In support of the membrane hypothesis, there is evidence that xenon 
can interact with lipid bilayers and change surface tension, bilayer volume, and pressure 
within the bilayer (110, 117). There is also evidence to suggest that the xenon dissolved 
in the membrane, despite its high lipid solubility, may not reside within the central core 
or tail region of the membrane. Rather, xenon may preferentially migrate to the 
amphiphilic region around the head groups after dissolving in the membrane (26, 117). 
This accumulation of xenon molecules in the membrane is believed to affect the structure 
and function of proteins embedded within the membrane (8, 41, 110). In particular, it is 
believed that changes in surface tension and pressure within the membrane result in 
conformational changes in ion channels within the synaptic terminals of neurons, 
resulting in decreased conduction, leading to anaesthesia (8, 26, 41, 110, 117).  
The greatest criticism levelled against much of the work done on the basis of the 
lipid hypothesis of narcosis, be that in vitro or in silico work, is the fact that most of these 
studies are done using dipalmitoylphosphatidylcholine (DPPC) bilayers as a membrane 
system (41). DPPC is an easily obtained egg yolk phospholipid which contains no double 
bonds to oxidize and readily forms into a biologically relevant liquid crystalline bilayer 
(41). Unfortunately it is also far too simple a system to accurately model a biological 
membrane. Living plasma membranes, especially those of neurons, contain a highly 
heterogeneous mixture of lipids, some saturated, some unsaturated, some charged, some 
neutral, as well as cholesterol (41). Biological membranes also contain various proteins 
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which make up approximately 50% of the mass of the membrane (41). In addition, it is 
now understood that the inner and outer leaflets of biological membranes are composed 
of different phospholipids and that the membrane is arranged laterally into distinct areas 
known as lipid rafts, which are composed of distinct lipids and proteins (23, 41). For 
example, nicotinic acetylcholine receptors in nerve and muscle cells require the presence 
of cholesterol and anionic phospholipids in their immediate vicinity in order to function 
properly (22, 41). The simple membrane systems often used experimentally are a poor 
approximation of biological membranes and thus their findings for the mechanism of 
narcosis must be taken with a grain of salt, as it were. At the same time, they do 
demonstrate that it is plausible that the membrane is, at lease in part, responsible for the 
mechanism of narcosis. 
There is also evidence that xenon anaesthesia/narcosis may be a product of 
interaction with proteins. Whereas most general anaesthetics have been shown to enhance 
the inhibitory activity of GABAA receptors, xenon seems to have little or no effect on 
them (46, 49). Instead it appears that xenon inhibits the excitatory action of N-methyl-D-
aspartate (NMDA) receptors and, to lesser extents, neuronal nicotinic receptors and 
TREK-1 two-pore K+ channels (34, 46, 58, 118). Interestingly, the NMDA receptor, a 
subtype of the glutamate receptor, is believed to be involved in learning, memory, and the 
perception of pain, which could explain xenon’s attractive pharmacological properties 
(46, 96). This appears to be a non-competitive inhibition of the NMDA receptor, so 
xenon should strongly inhibit neuronal transmission even in the presence of high 
glutamate concentrations in the synaptic cleft (46). This inhibition of the NMDA receptor 
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by xenon goes a long way toward explaining the analgesic and amnesic effects of xenon 
(46). 
X-ray crystallographic studies have also been performed in order to examine how 
and where xenon is interacting with various proteins. Unfortunately, membrane bound 
proteins such as the NMDA receptor are difficult to crystallize, so xenon has not been 
crystallized with the protein actually believed to be its target, but with soluble surrogate 
proteins. Xenon has been crystallized with urate oxidase, a prototype of various 
intracellular globular proteins, and with annexin V, a protein with structural and 
functional characteristics which allow it to be considered a prototype of the NMDA 
receptor (33, 34, 54). A single xenon molecule was found to bind to both of these 
proteins in a flexible, hydrophobic cavity (34). This is consistent with both the 
hydrophobicity of xenon and with the previous hypothesis that anaesthetic molecules 
exert their effect by binding proteins in these hydrophobic cavities (41). This suggests 
that it is plausible that xenon binds with the NMDA receptor, but that it is also capable of 
binding to a wide range of soluble intracellular proteins, consistent with the hypothesis 
that anaesthesia/narcosis is likely the ultimate product of multiple drug/protein 
interactions (41).  
Other anaesthetic compounds which are believed to operate primarily by 
inhibiting NMDA receptor signalling, such as nitrous oxide and ketamine, have been 
observed to increase both global and regional cerebral metabolism in humans (66, 68, 69, 
83, 90). Thus it would be expected that, if the anaesthetic action of xenon also operates 
primarily by inhibiting the NMDA receptor, that it should also increase both global and 
regional cerebral metabolism (97). Cerebral metabolic rates can be examined using 
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positron emission tomography (PET) and such studies have been performed (97).  
Because most general anaesthetics depress cerebral metabolism relative to conscious 
states, xenon anaesthesia was examined relative to propofol anaesthesia (3-5, 66). 
Contrary to expectations, it was found that xenon anaesthesia depressed cerebral 
metabolism both globally and regionally in the orbitofrontal, frontomedial, 
temporomedial, occipital, dorsolateral frontal, and lateral temporal cortices and thalamus 
(97). This suggests strongly that the mechanism of xenon anaesthesia/narcosis is not 
simply the inhibition of NMDA receptors. 
Conclusion 
Inert gasses clearly have physiological effects. To date, some work has been done 
to examine the effects of inert gasses on neurons, nerve conduction and consciousness, 
and a picture of how inert gases function as anaesthetics is beginning to emerge. The idea 
that inert gas narcosis can be reduced to a single cause is likely incorrect. The symptoms 
displayed vary widely, not only between different individuals, but also between different 
exposures for the same individual. The conditions required to bring about the onset of 
inert gas narcosis (ambient pressure, gas mix being breathed, temperature, psychological 
factors) also appear to vary widely. Hypotheses focusing exclusively on either cell 
membranes or protein interactions do not appear to tell the whole story. At this point in 
the research it would appear that there are elements of truth in both of these hypotheses. 
Continued research into both inert gas narcosis, and the mechanisms of general 
anaesthesia, particularly mechanisms pertaining to inhaled anaesthetics, are likely to 
further understanding of both conditions. The time may be nearing when, in order to truly 
understand the mechanisms of inert gas narcosis and general anaesthesia, hypotheses will 
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need to be able to bring together understanding which has been gained from both lipid- 
and protein-based models in order to construct a single model which can explain all the 
observations.  
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List of Figures 
 
Gas
Molecular 
Weight Volume
Lipid 
Solubility at 
37°C
Oil:water 
partition 
coefficient
Relative 
narcotic 
potency
Helium 4 2.370 0.015 1.70 0.23
Neon 20 1.709 0.019 2.07 0.28
Hydrogen 2 2.661 0.040 3.10 0.55
Nitrogen 28 3.913 0.067 5.25 1.00
Argon 40 3.218 0.140 5.32 2.33
Krypton 83.7 3.978 0.430 9.60 7.14
Xenon 131.3 3.105 1.700 20.00 25.64  
Figure 1. Narcotic potencies and physical properties of simple gasses. From (75). 
 
 
Figure 2. The critical volume hypothesis. Molecules of narcotic gases disolve in the cell membrane 
and cause it to swell. When the membrane reaches a certain volume narcosis is produced. Pressure 
reverses this narcotic effect by compressing the membrane. From (99). 
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Figure 3 Autoradiogram of rat brain section photoaffinity labeled with radioactive halothane. 
Degree of halothane binding is indicated by level of darkness; no other staining has been applied to the 
section. The binding shows little regional preference and is reduced to near-background levels in the 
presence of a tenfold excess of unlabeled halothane. The dramatic inhibition of labeling by non-radioactive 
halothane indicates that most halothane binding is saturable and specific, showing that many proteins could 
be involved in anesthetic action. From (39) 
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